Advertisement
Guest User

Untitled

a guest
Jan 24th, 2019
306
0
Never
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 173.89 KB | None | 0 0
  1. Ideal TOPite Genome (Annointed:)
  2.  
  3. Ideal TOPite mtDNA-haplogroup:
  4.  
  5. >http://www.phylotree.org/tree/index.htm
  6. >https://www.ncbi.nlm.nih.gov/pmc/articles/PMC447592/table/TB2/?report=objectonly
  7. >http://www.cell.com/ajhg/pdf/S0002-9297(12)00146-2.pdf
  8. >http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156632
  9. >Based on the pelvic and the skull morphologies, the specimen was determined to be a female
  10. >Additionally, a comb only used by the lady in the era which was found amongst the relics of the tomb suggests that the individual was from a female
  11. >However it was noted that male traits were also observed on the remarkably inclined forehead, everted gonial and developed mental regions on the mandible. DNA-based sex determination was attempted but the analysis did not obtain any results regarding the sex. It was presumed that the nuclear DNA could not be amplified from the ancient specimen of human remains
  12. >the stature was estimated to be 154.9 ± 4.6 cm
  13. >Consensus mtDNA haplotype of the Silla individual was 16220C, 16254G, 16298C, 16362C, 73G, 152C, 249d, 263G, 310.1C
  14. >the Silla individual’s haplotype belongs to East Asian haplogroup F1b1a
  15.  
  16. Ancestral Allele/Derived Allele/RNRS/L0/L1-6 - TOPite-Allele/Haplogroup
  17.  
  18. 73 - (G/A;G;G;G) - A/R0
  19. 146 - (C/T;C;C;T) - T/L1'2'3'4'5'6
  20. 152 - (C/T;C;T;C) - C/L1'2'3'4'5'6/N10b, I2'3, N1a3a1, N1a3a3, N1b
  21. 182 - (C/T;C;C;T) - C/L1'2'3'4'5'6
  22. 195 - (C/T;C;C;C) - C/L2'3'4'6
  23. 200 - (A/G;G;A;A) - G/L0
  24. 249 - (A/-;A;A;-) - -/R9c1a, F, R21, S5, M20, M31a1, M36d1, M40a1a, M59, M80, L3x2
  25. 263 - (G/A;G;A;G) - A/H2a2a1
  26. 593 - (T/C;T;T;T) - C/L1-6
  27. 750 - (G/A;G;G;G) - A/H2
  28. 1048 - (C/T;C;T;C) - C/L1'2'3'4'5'6
  29. 1438 - (G/A;G;G;G) - A/H2
  30. 1719 - (G/A;G;G;G) - A/R
  31. 2706 - (G/A;G;G;G) - A/H
  32. 2758 - (A/G;A;A;G) - G/L1'2'3'4'5'6
  33. 3516 - (C/A;C;A;C) - C/L1'2'3'4'5'6
  34. 4312 - (T/C;T;T;C) - T/L1'2'3'4'5'6
  35. 4769 - (G/A;G;G;G) - A/L1'2'3'4'5'6
  36. 5442 - (T/C;T;C;T) - T/L1'2'3'4'5'6
  37. 5460 - (G/A;G;G;G) - A/H1
  38. 6185 - (T/C;T;C;T) - T/L1'2'3'4'5'6
  39. 7028 - (T/C;T;T;T) - C/H
  40. 7146 - (G/A;G;A;G) - A/L2'3'4'5'6
  41. 8701 - (G/A;G;G;G) - A/N
  42. 8860 - (G/A;G;G;G) - A/L
  43. 9042 - (C/T;C;T;C) - C/L1'2'3'4'5'6
  44. 9347 - (A/G;A;G;A) - A/L1'2'3'4'5'6
  45. 10589 - (G/A;G;A;G) - G/L1'2'3'4'5'6
  46. 10644 - (T/C;T;T;C) - T/L0
  47. 10915 - (C/T;C;C;T) - C/L0
  48. 11719 - (A/G;A;A;A) - G/R0
  49. 11914 - (A/G;A;A;G) - A/L0
  50. 11915 - (C/T;C;T;C) - T/L0
  51. 12007 - (G/A;G;A;G) - G/L1'2'3'4'5'6
  52. 12705 - (T/C;T;T;T) - C/L1'2'3'4'5'6
  53. 12720 - (A/G;A;G;A) - A/L1'2'3'4'5'6
  54. 12810 - (A/G;A;A;A) - G/V3
  55. 13105 - (G/A;G;G;G) - G/HV0
  56. 13276 - (G/A;G;G;A) - G/L1'2'3'4'5'6
  57. 13506 - (T/C;T;T;C) - C/L2,3,4,6
  58. 14766 - (T/C;T;T;T) - C/HV
  59. 15301 - (G/A;G;G;A) - G/N
  60. 15326 - (G/A;G;G;G) - A/H2a2a
  61. 15775 - (A/G;A;A;A) - G/W5
  62. 16129 - (A/G;A;A;G) - G/L2,3,4,6
  63. 16187 - (T/C;T;T;C) - C/L2,3,4,6
  64. 16220 - (A/C;A;A;A) - C/F3b
  65. 16223 - (T/C;T;T;T) - C/R
  66. 16230 - (G/A;G;G;A) - G/L1'2'3'4'5'6
  67. 16254 - (A/G;A;A;A) - G/L3a
  68. 16278 - (T/C;T;T;C) - C/L1'2'3'4'5'6
  69. 16298 - (T/C;T;T;T) - C/L3h1a1, F3, R30b1, N10b, M8, W1d
  70. 16362 - (T/C;T;T;T) - C/L3h1b2, L3b, L3c, L3d5, F3, F4a1, R9b2, F1a4a, O1, N10, I3c, W5a
  71.  
  72. -
  73.  
  74. A
  75.  
  76. 001: 16q; ABAT (AA;) Position: 8750498
  77. \https://www.snpedia.com/index.php/Rs724159992
  78. \https://www.ncbi.nlm.nih.gov/clinvar/RCV000149900.1/
  79. \https://www.omim.org/entry/137150#0003
  80. >GATA-transaminase deficiency [...] c.275G-A transition
  81.  
  82. 001b: 16q; ABAT (TT;) Position: 8768220
  83. \https://www.snpedia.com/index.php/Rs724159990
  84. \https://www.ncbi.nlm.nih.gov/clinvar/RCV000149898.1/
  85. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=724159990
  86. >CTC [Leucine] -> TTC [Phenylalanine)
  87. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757431/#!po=21.0145
  88. \The variant (ABAT NM_000663.3 c.631C>T; NP_000654.2 p.Leu211Phe [...] Subject 1 (S1) [...] none of the individuals previously reported as having ABAT deficiency were noted to have mitochondrial dysfunction
  89.  
  90. 001c: 16q; ABAT (GG;) Position: 8768248
  91. \https://www.snpedia.com/index.php/Rs121434578
  92. \https://www.ncbi.nlm.nih.gov/clinvar/RCV000017603.27/
  93. \https://www.omim.org/entry/137150#0001
  94. >GABA-transaminase deficiency [...] 754A-G transition in the ABAT gene [...] Vmax was reduced to 25% of wildtype activity
  95.  
  96. 001d: 16q; ABAT (CC;) Position: 8781360
  97. \https://www.snpedia.com/index.php/Rs724159991
  98. \https://www.ncbi.nlm.nih.gov/clinvar/RCV000149899.1/
  99. \https://www.omim.org/entry/137150#0007
  100. >GABA-transaminase deficiency [...] c.1433T-C transition
  101.  
  102. 002: 16q; ABCC1 (AA;) Position: 48224287
  103. \https://www.snpedia.com/index.php/Rs17822931
  104. >also known as c.538G>A [...] It is commonly (T;T)(AA) for East Asians and (C;C)(GA/GG) for Europeans and Africans
  105. \https://www.omim.org/entry/607040#0001
  106. >The AA genotype corresponds to dry ear wax, and GA and GG to the wet type
  107. -^
  108.  
  109. 003: 9q; ABO (TT;) Position: 133273813
  110. \https://www.snpedia.com/index.php/Rs505922
  111. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514387/
  112. \https://www.ncbi.nlm.nih.gov/pubmed/22642827
  113. >The protective allele (T) for rs505922 is in complete [...] (LD) [...] with the O allele
  114. -^
  115.  
  116. 003b: 9q; ABO (GG;) Position: 133256205
  117. \https://www.snpedia.com/index.php/Rs7853989
  118. \http://www.redcross.org/images/MEDIA_CustomProductCatalog/m4440094_26_2_10.pdf
  119. >B (ABO*B1) nt 526C>G (rs7853989)
  120. -^
  121.  
  122. 003c: 9q; ABO (GG;) Position: 133256028
  123. \https://www.snpedia.com/index.php/Rs8176743
  124. \http://www.redcross.org/images/MEDIA_CustomProductCatalog/m4440094_26_2_10.pdf
  125. >B (ABO*B1) nt 703G>A (rs8176743)
  126. -^
  127.  
  128. 003d: 9q; ABO (CC;) Position: 133255935
  129. \https://www.snpedia.com/index.php/Rs8176746
  130. \http://www.redcross.org/images/MEDIA_CustomProductCatalog/m4440094_26_2_10.pdf
  131. >B (ABO*B1) nt 796C>A (rs8176746)
  132. -^
  133.  
  134. 003e: 9q; ABO (GG;) Position: 133255928
  135. \https://www.snpedia.com/index.php/Rs8176747
  136. \http://www.redcross.org/images/MEDIA_CustomProductCatalog/m4440094_26_2_10.pdf
  137. >B (ABO*B1) nt 803G>C (rs8176747)
  138. -^
  139.  
  140. 003f: 9q; ABO (-;-;) Position: 133257521
  141. \https://www.snpedia.com/index.php/Rs8176719
  142. \http://www.redcross.org/images/MEDIA_CustomProductCatalog/m4440094_26_2_10.pdf
  143. >O (ABO*O1) nt 261G/ΔG (rs8176719)
  144. -^
  145.  
  146. 004: 3q; ADAMTS9 (TT;) Position: 64705365
  147. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6795735
  148. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  149. >aEffect Allele: WHR increasing allele on the forward strand;
  150. >ADAMTS9, EA = C
  151.  
  152. 005: 15q; ADAMTSL3 (CC;) Position: 84037709
  153. \https://www.snpedia.com/index.php/Rs950169
  154. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631150/table/pgen-1000373-t001/?report=objectonly
  155. >rs950169 T frequency = Schizophrenia(0.23,) Controls(0.30)
  156. -^
  157.  
  158. 006: 14q; AKT1 (CC;) Position: 104772855
  159. \https://www.snpedia.com/index.php/Rs2494732
  160. \https://www.ncbi.nlm.nih.gov/m/pubmed/22831980/
  161. >C - greater odds of cannabis-associated psychosis
  162. -^
  163.  
  164. 006b: 14q; AKT1 (GG;) Position: 104796031
  165. \https://www.snpedia.com/index.php/Rs2498786
  166. \https://www.ncbi.nlm.nih.gov/m/pubmed/26178916/
  167. >The CC frequency of AKT1 rs2498786 polymorphism in AD with T2D group and AD control group was significantly higher than that in healthy control group
  168. -^
  169.  
  170. 006c: 14q; AKT1 (GG;) Position: 104772809
  171. \https://www.snpedia.com/index.php/Rs3803304
  172. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652804/
  173. >G - associated with Ashkenazi Jewish Centenarians
  174. -^
  175.  
  176. 007: 12q; ALDH2 (GG;) Position: 111803962
  177. \https://www.snpedia.com/index.php/Rs671
  178. >(G;G) Alcohol Flush: Normal, doesn't flush. Normal hangovers. Normal risk of Alcoholism. Normal risk of Esophageal Cancer. Disulfiram is effective for alcoholism
  179. \https://www.ncbi.nlm.nih.gov/m/pubmed/19706845/
  180. -^
  181.  
  182. 008: 18q; APCDD1 (CC;) Position: 10487921
  183. \http://publicatio.bibl.u-szeged.hu/4816/1/2746617_Nagy_JLife%20Sci.pdf
  184. >AGA (Androgenic Alopecia) patients - CC = n37, CT = n100, TT = 73
  185. >Controls - CC = n28, CT = n60, TT = 10
  186. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3185480
  187. -^
  188.  
  189. 009: 11q; APOC3 (CC;) Position: 116829268
  190. \https://www.snpedia.com/index.php/Rs2542052
  191. \https://www.ncbi.nlm.nih.gov/m/pubmed/16602826/
  192. >The prevalence of homozygosity for the -641C allele in the APOC3 promoter (rs2542052) was higher in centenarians (25%) and their offspring (20%) than in controls (10%)
  193. -^
  194.  
  195. 009b: 11q; APOC3 (AA;) Position: 116830844
  196. \https://www.snpedia.com/index.php/Rs147210663
  197. \http://www.nejm.org/action/showImage?doi=10.1056%2FNEJMoa1308027&iid=f02
  198. >A46T Effect allele = A, Triglyceride levels/allele = G(100% = n1,) A(53% of n1)
  199. -^
  200.  
  201. 010: Xq; AR (AA;) Position: 67545785
  202. \https://www.snpedia.com/index.php/Rs6152
  203. \https://www.ncbi.nlm.nih.gov/m/pubmed/21981665/
  204. >Three common polymorphisms of the AR gene were addressed: a StuI restriction-site polymorphism (rs6152, G>A) [...] Meta-analysis results identified a significant association between the G allele of the AR StuI polymorphism and the risk for AGA
  205. -^
  206.  
  207. 010b: Xq; AR (GG;) Position: 67350329
  208. \https://www.snpedia.com/index.php/Rs2223841
  209. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1226186/table/TB3/?report=objectonly
  210. >rs2223841 AGA(Androgenic alopecia) Frequency = A(0.954,) G(0.046,) Unaffected = A(0.688,) G(0.312)
  211. -^
  212.  
  213. 010c: Xq; AR (CAG(n = 36;) Position: 67545318
  214. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=193922933
  215. \http://omim.org/entry/313700#14
  216. \https://www.ncbi.nlm.nih.gov/m/pubmed/15198988/
  217. >There was on average a 1.7% decrease in activity for each additional glutamine repeat
  218. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833274/
  219. >The mean CAG repeat lengths were Afro-Caribbean 19.6 ± 3.2, Caucasian 21.9 ± 2.9, Hispanic 22.6 ± 3.1, and Thai 23.1 ± 3.3
  220. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402034/
  221. >A significant association was identified between transsexualism and the AR allele, with transsexuals having longer AR repeat lengths than non-transsexual male control subjects
  222.  
  223. 011: Xq; AR/EDA2R (CC;) Position: 67270282
  224. \https://www.snpedia.com/index.php/Rs4258142
  225. \https://images.nature.com/original/nature-assets/ncomms/2016/160301/ncomms10815/extref/ncomms10815-s1.pdf
  226. >Balding [...] rs4258142 Ancestral/Derived allele = C>T, Derived Allele frequency = CEU(85%,) YRI(0%,) CHB(100%,) NAM(99%,) CAN(88%)
  227. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4258142
  228. \https://www.ncbi.nlm.nih.gov/m/pubmed/11453914/
  229. >The prevalence of AGA in Korean men and women was lower than that in caucasians, as recorded in the literature. Korean men tend to have more frontal hairline preservation and show a more 'female pattern' of hair thinning than caucasians. Therefore, 'female pattern' should be added to the classification of AGA
  230. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1113949/
  231. >By the age of 30, 30% of white men have androgenetic alopecia; by the age of 50, 50% do [...] White men are four times more likely to than black men develop premature balding (Note: white rate of AGA / 4 = Black AGA rate = Age30(7.5%,) Age50(12.5%) Therefore YRI-allele = AGA-, HCB-allele = AGA, and CEU-allele = AGA+
  232. -^
  233.  
  234. 012: 20q; ASIP (TT;) Position: 34262569
  235. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2424984
  236. \https://www.ncjrs.gov/pdffiles1/nij/grants/223980.pdf
  237. >Six markers have significant effects on hair total melanin: [...] dbSNPrs2424984 (ASIP) [...] When each are considered separately, these markers account for [...] 19.9% [...] (respectively) of the total trait variation [...] Five markers showed a significant effect on skin reflectance: [...] dbSNPrs2424984 (ASIP) [...] 15.6% [...] of the total trait variance [...] Eye color was significantly influenced by 5 markers: [...] and dbSNPrs2424984 (ASIP). When considered separately as single markers, these account for [...] 3.4% of the total trait variance
  238. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2424984
  239. >Frequency = CEU(CC=0.017, CT=0.194, TT=0.787,) HCB(CC=0.069, CT=0.418, TT=0.511,) YRI(CC=0.619, CT=0.345, TT=0.035)
  240.  
  241. 012b: 20q; ASIP (GG;) Position: 34262569
  242. \https://www.snpedia.com/index.php/Rs1015362
  243. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1015362
  244. >Frequency = CEU(AA=0.053, AG=0.424, GG=0.522,) HCB(AA=0.023, AG=0.209, GG=0.767,) YRI(AA=0.681, AG=0.300, GG=0.017)
  245. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700213/
  246. >The haplotype near ASIP(rs4911414[T] and rs1015362[G]) was significantly associated with fair skin color (OR, 2.28; 95% CI, 1.46–3.57
  247. -^
  248.  
  249. 012c: 20q; ASIP (TT;) Position: 34141638
  250. \https://www.snpedia.com/index.php/Rs4911414
  251. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4911414
  252. >Frequency = CEU(GG=0.450, GT=0.459, TT=0.090,) HCB(GG=0.761, GT=0.214, TT=0.023,) YRI(GG=0.705, GT=0.276, TT=0.017)
  253. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700213/
  254. >The haplotype near ASIP(rs4911414[T] and rs1015362[G]) was significantly associated with fair skin color (OR, 2.28; 95% CI, 1.46–3.57
  255.  
  256. -^
  257.  
  258. 012d: 20q; ASIP (AA;) Position: 34269192
  259. \https://www.snpedia.com/index.php/Rs6058017
  260. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=ss1364626247
  261. >Frequency = EUR(A=0.896, G=0.103,) EAS(A=0.787, G=0.212,) AFR(A=0.208, G=0.791)
  262. \http://www.utm.utoronto.ca/~parraest/profile/PDF%20files/Bonilla%20et%20al.,%202005a.pdf
  263. >A single-nucleotide poly- morphism (SNP) in the 3¢-untranslated region (UTR) of ASIP (noted as g.8818A>G in the literature, dbSNP# rs6058017) has been reported to be associated with dark hair and brown eyes in European Americans
  264.  
  265. -^
  266.  
  267. 013: 1q; ASPM (GG;) Position: 197101567
  268. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=41310927
  269. >Ancestral Allele: T
  270. >Fwd=T-to-A=Rev/Fwd=C-to-G=Rev, so T = A and C = G
  271. >A(S, Ser) -> G(G, Gly)
  272. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=ss1294110430
  273. >EUR(T=0.589, C=0.410,) EAS(T=0.836, C=0.163,) AFR(T=0.956, C=0.043)
  274. \http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0034243
  275. >ASPM A44871G (rs41310927,Ser2562Gly [...] We found a significant positive correlation between Tone Perception and the [...] derived alleles for ASPM A44871G [...] Table 1. Association between load of ASPM-G allele and neural repetition suppression to tone repeat (1) and tone-change (2) conditions
  276. \https://academic.oup.com/hmg/article/15/12/2025/2355898
  277. >For ASPM, each additional A44871G allele was associated with a non- significant (df=1, 115, P=0.55) 10.9 cc decrease in brain volume [...] The 95% confidence interval for the change in brain volume per A44871G allele was -46.8 cc [...] We cannot exclude the possibility that these alleles might nonetheless be associated with small differences in brain volume [...]
  278. \http://science.sciencemag.org/content/309/5741/1720.long
  279. >Frequency of ASPM D-allele = Russians(38%,) French(50%,) Orkney Islands(40.6%,) Papuan(59.7%,) South African Bantu(0%,) San(0%,) Bakola Pygmy(0%)
  280. \http://www.sciencedirect.com/science/article/pii/S016028960200137X
  281. >African-descended people (Blacks) average cranial capacities of 1267 cm3, European-descended people (Whites) 1347 cm3 [...] It must be concluded that the race differences in average brain size are securely established [...] Blacks average an IQ of 85, Whites 100
  282. >Note: 1347 - 1267 = 80 / 2 = 40, therefore two copies of the 44871G allele could explain the observed 80cc of difference between blacks and whites
  283. -^
  284.  
  285. 013b: 1q; ASPM (CC;) Position: 197117000
  286. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10922168
  287. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/#!po=16.6667
  288. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  289. >rs10922168 42cc -/+ 38
  290. \http://www.pnas.org/content/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  291. >rs10922168 T/C Minor allele frequency = 0.17
  292. -^
  293.  
  294. 013c: 1q; ASPM (AA;) Position: 197101312
  295. \http://jmg.bmj.com/content/42/9/725
  296. >ASPM mutations identified in patients with primary microcephaly [...] In addition, we also identified four non-synonymous [...] 7939C->A [...] SNPs
  297. \https://www.snpedia.com/index.php/Rs3762271
  298. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3762271
  299. >NM_018136.4:c.7939C>A
  300. \http://journals.sagepub.com/doi/full/10.1177/1099800416630621
  301. >The CC genotype of rs3762271 was significantly associated with birth weight [...] and body length
  302. -^
  303.  
  304. B
  305.  
  306. 001: 6q; BAT2 (GG;) Position: 31635190
  307. \https://www.snpedia.com/index.php/Rs1046089
  308. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992315/
  309. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992315/table/T1/?report=objectonly
  310. >G allele = 0.48x odds of severe Malaria
  311. -^
  312.  
  313. 002: 4q; BMP2K (AA;) Position: 78865702
  314. \https://www.snpedia.com/index.php/Rs2288255
  315. \https://www.ncbi.nlm.nih.gov/m/pubmed/19927351/
  316. >1379 G/A (rs2288255) [...] frequency of A allele in the BMP2K gene 1379 G/A polymorphism showed a significant difference between cases and controls [...] subjects with either AA or AG genotype show higher risk than GG genotype
  317. \http://iovs.arvojournals.org/article.aspx?articleid=2124443
  318.  
  319. 002b: 4q; BMP2K (GG;) Position: 78911552
  320. \https://www.snpedia.com/index.php/Rs12507099
  321. \https://www.ncbi.nlm.nih.gov/m/pubmed/19927351/
  322. >3171 C/G (rs12507099) [...] 3171 C/G polymorphism was not significant
  323. \http://iovs.arvojournals.org/article.aspx?articleid=2124443
  324. -^
  325.  
  326. 003: 14q; BMP4 (TT;) Position: 53950804
  327. \https://www.snpedia.com/index.php/Rs17563
  328. \https://www.ncbi.nlm.nih.gov/pubmed/21034624?dopt=Abstract
  329. >ossification of the posterior longitudinal ligament (OPLL) [...] the frequency of "TT" genotype in male OPLL patients was significantly higher than in male controls [...] A significant difference was also observed between the 6007C>T polymorphism and the number of ossified cervical vertebrae in OPLL patients
  330. -^
  331.  
  332. 004: 9q; BNC2 (CC;) Position: 16680140
  333. \https://www.snpedia.com/index.php/Rs10738445
  334. \https://www.ncbi.nlm.nih.gov/m/pubmed/28342042/
  335. >Adolescent idiopathic scoliosis [...] We found that patients have a significantly higher frequency of CC than the controls
  336. \https://www.ncbi.nlm.nih.gov/m/pubmed/26211971/
  337. >At higher doses, delayed or disturbed pigmentation was also observed in the embryos with severe body curva- ture
  338. \https://www.omim.org/entry/608669
  339. >A/A allele rendered the chromatin inaccessible, and the enhancer element was only slightly active, resulting in low expression of BNC2 and thus light skin pigmentation
  340. -^
  341.  
  342. 004b: 9q; BNC2 (AA;) Position: 16885019
  343. \https://www.snpedia.com/index.php/Rs12350739
  344. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=12350739
  345. \https://www.ncbi.nlm.nih.gov/m/pubmed/24916375/
  346. >When the rs12350739-AA allele is present, the chromatin at the region surrounding rs12350739 is inaccessible and the enhancer element is only slightly active, resulting in low expression of BNC2, corresponding with light skin pigmentation
  347. -^
  348.  
  349. 004c: 9q; BNC2 (TT;) Position: 16864523
  350. \https://www.snpedia.com/index.php/Rs2153271
  351. \http://journals.plos.org/plosgenetics/article/figure?id=10.1371/journal.pgen.1000993.t002
  352. >Freckling associated with rs2153271 - assumed to be T based on CEU frequency
  353. -^
  354.  
  355. 004d: 9q; BNC2 (GG;) Position: 16464982
  356. \https://www.snpedia.com/index.php/Rs10733310
  357. \https://www.ncbi.nlm.nih.gov/m/pubmed/28057405/
  358. >association between SNP rs10733310 [...] and pigment spots [...] Pigment Forearm = GG(2.9,) TG(2.5,) TT(2.1)
  359. -^
  360.  
  361. C
  362.  
  363. 001: 3q; CCR2 (AA;) Position: 46357717
  364. \https://www.snpedia.com/index.php/Rs1799864
  365. \https://www.ncbi.nlm.nih.gov/m/pubmed/12556692/
  366. >individuals with one or two copies of CCR2-64I had a 58% lower risk of AIDS
  367. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1799864
  368. >Ancestral Allele: G [...] GTC [Valine] -> ATC [Isoleucine]
  369. -^
  370.  
  371. 002: 3q; CCR5 (0T;) Position: 46373456
  372. \https://www.snpedia.com/index.php/Rs333
  373. \https://www.ncbi.nlm.nih.gov/m/pubmed/8898752/
  374. \https://www.ncbi.nlm.nih.gov/m/pubmed/8898752/
  375. >A 32-nucleotide deletion (delta 32) within the beta-chemokine receptor 5 (CCR5) gene has been described in subjects who remain uninfected despite extensive exposure to HIV-1
  376. -^
  377.  
  378. 003: 16q; CETP (GG;) Position: 56982180
  379. \https://www.snpedia.com/index.php/Rs5882
  380. \https://www.ncbi.nlm.nih.gov/m/pubmed/20068209/
  381. >Compared with isoleucine homozygotes, valine homozygotes had significantly slower memory decline
  382. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5882
  383. >GTC [Valine] -> ATC [Isoleucine]
  384. -^
  385.  
  386. 003b: 16q; CETP (TT;) Position: 56960616
  387. \https://www.snpedia.com/index.php/Rs17231506
  388. \https://www.ncbi.nlm.nih.gov/m/pubmed/23372063/
  389. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=17231506
  390. >rs17231506 (CETP c.-1337 C>T) [...] significantly modulate the capacity of whole-plasma to mediate cholesterol efflux from human macrophages
  391. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684899/bin/NIHMS726871-supplement.docx
  392. >Supplementary Table 9, rs17231506 HDL-C = CC(48.99,) CT(51.23,) TT(54.01)
  393. -^
  394.  
  395. 004: 17q; CD79B (TT;) Position: 63928899
  396. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7921
  397. >Ancestral Allele = C [...] Fwd = C/T, Rev = A/G, C-A/T-G, so C=A, G=T [...] Frequency = CEU(CC=0.513, CT=0.415, TT=0.070,) HCB(CC=0.906, CT=0.069, TT=0.023,) YRI(CC=0.510, CT=0.361, TT=0.127)
  398. \https://www.sciencedirect.com/science/article/pii/S0888754397951715
  399. >Sequence analysis of the region between the GH1 gene and its most proximal HS (HSI) revealed a perfect match to the B-lymphocyte-specific CD79b gene
  400. \https://www.sciencedirect.com/science/article/pii/S000292971000594X#!
  401. >Table 1. Sixty-Four Loci Showing Significant Evidence for Association with Adult Height [...] rs7921, Effect Allele = A, Effect(0.34)
  402.  
  403. 005: 9q; CDK5RAP2 (GG;) Position: 120373094
  404. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4836817
  405. >Ancestral Allele: C [...] Frequency = CEU(CC=0.477, CT=0.486, TT=0.035,) HCB(CC=0.813, CT=0.162, TT=0.023,) YRI(CC=0.875, CT=0.116, TT=0.008,) CHB(CC=0.804, CT=0.195, TT=0.000)
  406. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  407. >rs4836817, Population(Males,) Effect Size([-]42-/+24cm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  408. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  409. >rs4836817 = Major/minor allele = G(=C)/T
  410. >Note: 42+24=66cc, CEU(0(*0.477=0.477,)-66(*0.486=-32.076,)-132(*0.035=-4.62,)=-36.219cc) HCB(0(*0.813=0.813,)-66(*0.162=-10.692,)-132(*0.023=-3.036,)=-12.915cc) YRI(0.875=0.875,)-66(*0.116=-7.656,)-132(*0.008=-1.056,)=-7.837cc)
  411.  
  412. 005b: 9q; CDK5RAP2 (GG;) Position: 120382296
  413. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10818453
  414. >Ancestral Allele: A [...] Frequency = CEU(AA=0.035, AG=0.526, GG=0.437,) HCB(AA=0.069, AG=0.279, GG=0.651,) YRI(AA=0.144, AG=0.441, GG=0.414
  415. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  416. >rs10818453, Population(Males,) Effect Size([-]63-/+35cm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  417. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  418. >rs10818453 = Major/minor allele = G/A
  419. >Note: 63+35=98cc, CEU(-196(*0.035=-6.86,)-98(*0.526=-51.548,)0(0.437=0.437)=-57.971cc) HCB(-196(*0.069=-13.524,)-98(*0.279=-27.342,)0(0.651=0.651)=-40.215cc) YRI(-196(*0.144=-28.224,)-98(*0.441=-43.218,)0(0.414=0.414)=-71.028cc)
  420.  
  421. 005c: 9q; CDK5RAP2 (GG;) Position: 120388175
  422. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4836819
  423. >Ancestral Allele = G [...] Frequency = CEU(AA=0.033, AG=0.576, GG=0.389,) HCB(AA=0.088, AG=0.177, GG=0.733,) YRI(AA=0.250, AG=0.466, GG=0.283)
  424. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  425. >rs4836819, Population(Males,) Effect Size([-]61-/+34cm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  426. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  427. >rs4836819 = Major/minor allele = G/A
  428. >Note: 61+34=95cc, CEU(-190(*0.033=-6.27,)-95(*0.576=-54.72,)0(0.389=0.389)=-60.601cc) HCB(-190(*0.088=-16.72,)-95(*0.177=-16.815,)0(0.733=0.733)=-32.802cc) YRI(-190(*0.250=-47.5,)-95(*0.466=-44.27,)0(0.283=0.283)=-91.487cc)
  429.  
  430. 005d: 9q; CDK5RAP2 (GG:) Position: 120389401
  431. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4836820
  432. >Ancestral Allele = G [...] Frequency = CEU(AA=0.017, AG=0.513, GG=0.469,) HCB(AA=0.069, AG=0.116, GG=0.813,) YRI(AA=0.000, AG=0.283, GG=0.716)
  433. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  434. >rs4836820, Population(Males,) Effect Size([-]72-/+33cm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  435. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  436. >rs4836820 = Major/minor allele = G/A
  437. >Note: 72+33=105cc, CEU(-210(*0.017=-3.57,)-105(*0.513=-53.865,)0(0.469=0.469)=-60.601cc) HCB(-210(*0.069=-14.49,)-105(*0.116=-12.18,)0(0.813=0.813)=-25.857cc) YRI(-210(*0.000=-0.00,)-105(*0.283=-29.715,)0(0.716=0.716)=-28.999cc)
  438.  
  439. 005e: 9q; CDK5RAP2 (GG;) Position: 120394313
  440. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7859743
  441. >Ancestral Allele = G [...] Frequency = CEU(AA=0.026, AG=0.522, GG=0.451,) HCB(AA=0.093, AG=0.186, GG=0.720,) YRI(AA=0.203, AG=0.469, GG=0.327)
  442. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  443. >rs7859743, Population(Males,) Effect Size([-]60-/+33cm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  444. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  445. >rs7859743 = Major/minor allele = G/A
  446. >Note: 60+33=93cc, CEU(-186(*0.026=-4.836,)-93(*0.522=-48.546,)0(0.451=0.451)=-52.931cc) HCB(-186(*0.093=-17.298,)-93(*0.186=-17.298,)0(0.720=0.720)=-33.876cc) YRI(-186(*0.203=-37.758,)-93(*0.469=-43.617,)0(0.327=0.327)=-81.048cc)
  447.  
  448. 005f: 9q; CDK5RAP2 (GG;) Position: 120403882
  449. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2297453
  450. >Ancestral Allele = G [...] Frequency = CEU(AA=0.026, AG=0.455, GG=0.517,) HCB(AA=0.162, AG=0.395, GG=0.441,) YRI(AA=0.168, AG=0.460, GG=0.371)
  451. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  452. >rs2297453, Population(Males,) Effect Size([-]72-/+34cm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  453. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  454. >rs2297453 = Major/minor allele = G/A
  455. >Note: 72+34=106cc, CEU(-212(*0.026=-5.512,)-106(*0.455=-48.23,)0(0.517=0.517)=-53.225cc) HCB(-212(*0.162=-34.344,)-106(*0.395=-17.298,)0(0.441=0.441)=-51.201cc) YRI(-212(*0.168=-35.616,)-106(*0.469=-49.714,)0(0.371=0.371)=-81.048cc)
  456.  
  457. 005g: 9q; CDK5RAP2 (GG;) Position: 120407440
  458. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2282168
  459. >Ancestral Allele = G [...] Frequency = CEU(CC=0.017, CG=0.424, GG=0.557,) HCB(CC=0.046, CG=0.116, GG=0.837,) YRI(CC=0.035, CG=0.312, GG=0.652)
  460. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  461. >rs2282168, Population(Males,) Effect Size([-]84-/+35wcm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  462. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  463. >rs2282168 = Major/minor allele = G/A(=C)
  464. >Note: 84+35=119cc, CEU(-238(*0.017=-4.046,)-119(*0.424=-50.456,)0(0.557=0.557)=-53.945cc) HCB(-238(*0.046=-10.948,)-119(*0.116=-13.804,)0(0.837=0.837)=-23.915cc) YRI(-238(*0.035=-8.33,)-119(*0.312=-37.128,)0(0.652=0.652)=-44.806cc)
  465.  
  466. 005h: 9q; CDK5RAP2 (AA;) Position: 120407793
  467. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1888893
  468. >Ancestral Allele = G [...] Frequency = CEU(AA=0.544, AG=0.428, GG=0.026, GT=0.000) HCB(AA=0.744, AG=0.186, GG=0.069, GT=0.000,) YRI1/YRI2/BANTU(AA=0.333, AG=0.333, GG=0.000, GT=0.333)
  469. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  470. >rs1888893, Population(Males,) Effect Size([-]73-/+35wcm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  471. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  472. >rs1888893 = Major/minor allele = G/G
  473. >Note: 73+35=108cc, does not include T-allele, CEU(0(*0.544=0.544,)-108(*0.428=-45.68,)-216(*0.026=-5.616)=-50.752cc) HCB(0(*0.774=0.774,)-108(*0.186=-20.088,)-216(0.069=-14.904)=-34.218cc) YRI(0(*0.500=0.500,)-108(*0.500=-54.0,)-216(0.000=-0.000)=-53.5cc)
  474.  
  475. 005i: 9q; CDK5RAP2 (AA;) Position: 120407889
  476. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=914592
  477. >Ancestral Allele = A [...] Frequency = CEU(AA=0.554, AG=0.427, GG=0.018,) HCB(AA=0.833, AG=0.119, GG=0.047,) YRI(AA=0.666, AG=0.297, GG=0.036)
  478. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  479. >rs914592, Population(Males,) Effect Size([-]83-/+35wcm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  480. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  481. >rs914592 = Major/minor allele = G/G
  482. >Note: 83+35=118cc, CEU(0(*0.554=0.554,)-118(*0.427=-50.386,)-236(*0.018=-4.248)=-54.08cc) HCB(0(*0.833=0.833,)-118(*0.119=-14.042,)-236(*0.047=-11.092)=-24.301cc) YRI(0(*0.666=0.666,)-118(*0.297=-35.046,)-236(0.036=-8.496)=-42.876cc)
  483.  
  484. 005j: 9q; CDK5RAP2 (CC;) Position: 120407932
  485. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=914593
  486. >Ancestral Allele = A [...] Frequency = CEU(CC=0.557, CG=0.424, GG=0.017,) HCB(CC=0.837, CG=0.116, GG=0.046,) YRI(CC=0.637, CG=0.300, GG=0.061)
  487. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/
  488. >rs914593, Population(Males,) Effect Size([-]80-/+35.6wcm3 [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  489. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  490. >rs914593 = Major/minor allele = G/G
  491. >Note: 80+35.6=115.6cc, CEU(0(*0.557=0.557,)-115.6(*0.424=-49.0144,)-231.2(*0.017=-3.9304)=-54.08cc) HCB(0(*0.837=0.837,)-115.6(*0.116=-13.409,)-231.2(*0.046=-10.635)=-23.207cc) YRI(0(*0.637=0.637,)-115.6(*0.300=-34.68,)-231.2(0.036=-8.3232)=-42.3662cc)
  492. \http://www.sciencedirect.com/science/article/pii/S016028960200137X
  493. >It must be concluded that the race differences in average brain size are securely established [...] In the US and around the world, East Asians and their descendants average an IQ of about 106, Europeans and their descendants about 100, and Africans and their descendants about 85. The lowest average IQ scores are reported for sub-Saharan Africa, about 70 [...] Their study found that East Asians, Europeans, and Africans averaged cranial volumes of 1415, 1362, and 1268 cm3
  494. >Calculated average Racial cc adjustment = HCB(-302.507cc = +231.898 of AFR,) CEU(-534.405cc = AFR +10.5902,) YRI(-544.9952cc.) In 8/10 instances, the Derived allele is associated with lower brain volume/cortical area. 1,812.9952cc - 544.9952cc = 1268cc, 1,812.9952cc - 534.405cc = 1,278.5902cc, Kenya(Height=67",) Europe(Height=71",) 71" / 67" = 1.0597 * 1,278.5902cc = 1,354.92203494cc. 1,812.9952cc - 302.507cc = 1,510.4882cc China(Height=66.5",) 66.5" / 71" = 0.9366 * 1,510.4882cc = 1,414.72324812cc. The Amud neanderthal (55Kya, 1740cc, Height=70") 72.89655172413793"(70 * 1.041379310344828 = 72.89655172413793) / 70" = 1.041379310344828(1,812 / 1740 = 1.041379310344828) * 1740 = 1,812cc. The correlation between brain size and IQ is 0.33;
  495. \http://www.people.vcu.edu/~mamcdani/Big-Brained%20article.pdf
  496. >The best unbiased estimate of the population correlation between brain volume and intelligence is 0.33
  497. >Therefore, if 1362cc = 100IQ, than 100IQ = 449.46, 1268cc = 85IQ, than 85IQ = 418.44, 449.46 / 418.44 = 1.074132492113565 * 1268cc = 1,362cc, 1.074132492113565 - 1 = 0.074132492113565 / 2 = 0.037066246056782 + 1 = 1.037066246056782 * 1268cc = 1,315cc - 47 = 1268, 1,315 + 47 = 1362cc, 1.037066246056782 * 85IQ = 88.15063091482647. Therefore, 1362cc = 100IQ = 449.46, and 449.46 / n1(cc * 0.33) = n2 * n3(cc) = n4, or n1(0.33 * cc) / 449.46 = n3 * (1362cc/100IQ) = n4 = cc/IQ. Therefore n1=597.96(0.33 * 1,812cc) / 449.46 = n3(1.330396475770925) * (1,812cc/133IQ) = n4. 56 / 72.89655172413793 = 0.768211920529801 * 1,812cc = 1,392cc, 1,392cc / 1362cc = 1.022026431718062 * 100IQ = 102IQ.
  498.  
  499. 006: 7q; CDK6 (GG;) Position: 92607515
  500. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4272
  501. >Ancestral Allele = A [...] Frequency = CEU(AA=0.513, AG=0.433, GG=0.053,) HCB(AA=0.813, AG=0.139, GG=0.046,) YRI(AA=0.787, AG=0.185, GG=0.026)
  502. \https://www.sciencedirect.com/science/article/pii/S000292971000594X#!
  503. >Table 1. Sixty-Four Loci Showing Significant Evidence for Association with Adult Height [...] rs4272, Effect Allele = A, Effect(-0.46)
  504.  
  505. 007: 4q; CLOCK (CC;) Position: 55435202
  506. \http://snpedia.com/index.php/Rs1801260
  507. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1166621/
  508. >Clock Mutants Find Cocaine More Rewarding
  509. \https://www.ncbi.nlm.nih.gov/m/pubmed/17221848/
  510. >carriers of the C allele had a similar degree of severity of depression, but showed higher activity levels in the evening, a delayed sleep onset (mean 79 min later), and a reduced amount of sleep during the night (mean 75 min less)
  511. -^
  512.  
  513. 008: 8q; CNGB3 (TT;) Position: 86632768
  514. \https://www.snpedia.com/index.php/Rs121918344
  515. \https://omim.org/entry/605080#0001
  516. >total colorblindness, photophobia, nystagmus, 20/200 visual acuity, and a normal-appearing retina [...] Sequence analysis of exons showed a C-to-T transition
  517.  
  518. 009: 6q; CNR1 (GG;) Position: 88143916
  519. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1049353
  520. >Ancestral Allele = G [...] Frequency = CEU(AA=0.044, AG=0.375, GG=0.580,) HCB(AA=0.000, AG=0.139, GG=0.860,) YRI(AA=0.000, AG=0.176, GG=0.823)
  521. \https://link.springer.com/article/10.1007%2Fs12020-007-0022-y
  522. >G1422A variant (rs1049353) [...] In obese men, CNR1 1422 A/A genotype was significantly associated with higher WHR (P = 0.009) and waist circumference (P = 0.008)
  523.  
  524. 009b: 6q; CNR1 (CC;) Position: 88147601
  525. \https://www.snpedia.com/index.php/Rs806374
  526. \https://www.ncbi.nlm.nih.gov/m/pubmed/28930056/
  527. >rs806374, was significantly associated with individual differences in level-but not growth-of cannabis use over time, such that C carriers were more likely to use cannabis more frequently
  528.  
  529. 009c: 6q; CNR1 (CC:) Position: 88149004
  530. \https://www.snpedia.com/index.php/Rs806377
  531. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155489/
  532. >To further analyse genotypic differences for each SNP that were significantly associated with gaze duration for happy faces, post hoc t-tests were conducted. In rs806377, the CC genotype was associated with longer gaze duration than the CT genotype
  533.  
  534. 009d: 6q; CNR1 (CC;) Position: 88149832
  535. \https://www.snpedia.com/index.php/Rs806378
  536. \https://www.ncbi.nlm.nih.gov/m/pubmed/20107430/
  537. >A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia [...] rs806378 was nominally associated with weight gain in patients of European ancestry treated with clozapine or olanzapine [...] This translated into approximately 2.2 kg more weight gain in patients carrying the T allele than the patients homozygous for the CC genotype
  538.  
  539. 009e: 6q; CNR1 (AA;) Position: 88154934
  540. \https://www.snpedia.com/index.php/Rs806380
  541. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=806380
  542. >Ancestral Allele = A
  543. \https://www.ncbi.nlm.nih.gov/m/pubmed/16917946/
  544. >Univariate (single-marker) association tests demonstrated that SNP rs806380, located in intron 2 of the CNR1 gene, was significantly associated with developing one or more cannabis dependence symptoms, with the G allele having a protective effect
  545.  
  546. 010: 1q; CNR2 (CC;) Position: 23874672
  547. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2229579
  548. >Ancestral Allele = C
  549. \https://www.ncbi.nlm.nih.gov/m/pubmed/23846977/
  550. >Association of single-nucleotide polymorphisms in the cannabinoid receptor 2 gene with schizophrenia in the Han Chinese population [...] For rs2229579, the T allele frequencies of the case group were higher than the control
  551.  
  552. 010b: 1q; CNR2 (GG;) Position: 23875153
  553. \http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2501431
  554. >Fwd = A/G, Rev = C/T, A-T/G-C
  555. \https://www.snpedia.com/index.php/Rs2501431
  556. \https://www.ncbi.nlm.nih.gov/m/pubmed/29353877/
  557. >Gene variants and educational attainment in cannabis use: mediating role of DNA methylation
  558. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802451/table/Tab5/?report=objectonly
  559. >Frequency = rs2501431, AA(Controls = 47.37%, MJ-Users = 58.97%,) AG(Controls = 41.05%, MJ-Users = 41.03%,) GG(Controls = 11.58%, MJ-Users = 0.00%)
  560. \https://www.ncbi.nlm.nih.gov/m/pubmed/26055357/
  561. >TT genotype of rs2501431 [...] had lower lumbar spine BMD and femoral neck BMD compared with the other genotypes
  562.  
  563. 010c: 1q; CNR2 (TT;) Position: 23875430
  564. \https://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2501432
  565. \https://www.snpedia.com/index.php/Rs2501432
  566. \https://www.ncbi.nlm.nih.gov/m/pubmed/23846977/
  567. >Association of single-nucleotide polymorphisms in the cannabinoid receptor 2 gene with schizophrenia in the Han Chinese population [...] rs2501432C/T [...] Our results suggest that the T allele of rs2501432 may be a protective factor, particularly in males
  568.  
  569. 010d: 1q; CNR2 (GG;) Position: 23875429
  570. \https://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=35761398
  571. >CAA(Q, Gln) -> CGG(R, Arg) [...] Fwd = C/T, A-C/G-T
  572. \https://www.snpedia.com/index.php/Rs35761398
  573. \https://www.ncbi.nlm.nih.gov/m/pubmed/23707465/
  574. >Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C [...] Patients with the CB2-63 QQ variant had higher serum levels of aminotransferase than those with the CB2-63 QR or RR variants [...] Patients with the CB2-63 QQ variant had higher serum levels of aminotransferase than those with the CB2-63 QR or RR variants [...] The CB2-63 QQ variant of CNR2 is associated with more severe inflammation and hepatocellular necrosis in patients with HCV infection
  575.  
  576. 010e: 1q; CNR2 (AA;) Position:
  577. \https://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=41311993
  578. >Fwd = G/T, Rev = C/A, G-C/T-A [...] C(L, Leu) -> A(I, Ile) [...] Frequency = EAS(G=1.000, T=0.000,) EUR(G=0.991, T=0.008,) AFR(G=1.000, T=0.000,) AMR(G=0.998, T=0.001,) SAS(G=0.996, T=0.003)
  579. \https://www.snpedia.com/index.php/Rs41311993
  580. \https://www.ncbi.nlm.nih.gov/m/pubmed/21658778/
  581. >Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor [...] rs41311993 (524C>A; Leu133Ile [...] A statistically significant association was found between BD and the CNR2 524C>A; Leu133Ile
  582.  
  583. 011: 22q; COMT (AA;) Position: 19963748
  584. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4680
  585. >GTG [Valine] -> ATG [Methionine]
  586. \Citation: https://www.snpedia.com/index.php/Rs4680
  587. >COMT gene
  588. >(A;A): (worrier) advantage in memory and attention tasks
  589. >(A;G): multiple associations, see details
  590. >(G;G): (warrior) multiple associations, see details
  591. \https://www.ncbi.nlm.nih.gov/m/pubmed/17008817/
  592. >Those with valine (Val158) alleles have increased greater COMT activity and lower prefrontal extracellular dopamine compared with those with the methionine
  593. -^
  594.  
  595. 012: 5q; CPEB4 (GG;) Position: 173362458
  596. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6861681
  597. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  598. >aEffect Allele: WHR increasing allele on the forward strand;
  599. >CPEB4, EA = A
  600.  
  601. 013: Xq; CSF2RA (CC;) Position: 1029445
  602. \https://www.snpedia.com/index.php/Rs4129148
  603. \http://www.nature.com/mp/journal/v12/n6/fig_tab/4001983f2.html#figure-title
  604. \https://www.nature.com/articles/4001983
  605. >homozygosity for the C allele (−strand) was significantly associated with schizophrenia
  606. -^
  607.  
  608. 013b: Xq; CSF2RA (GG;) Position: 1294564
  609. \https://www.snpedia.com/index.php/Rs28414810
  610. \http://www.nature.com/mp/journal/v12/n6/fig_tab/4001983t2.html#figure-title
  611. \https://www.nature.com/articles/4001983/tables/2
  612. >rs28414810 G allele Frequency = Schizophrenia(0.80,) Controls(0.63)
  613. -^
  614.  
  615. 014: 15q; CYP1A2 (AA;) Position: 74750296
  616. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=72547513
  617. >C allele = F[Phe] -> A allele = L[Leu]
  618. \http://jpet.aspetjournals.org/content/308/1/300.long
  619. >Metabolism and Kinetic Characterization of 7-Ethoxyresorufin O-Deethylation by CYP1A2 Variant Enzymes
  620. >The F186L Vmax value was 16-fold lower (p < 0.05) than that of the wild type
  621. \https://en.wikipedia.org/wiki/2-Hydroxyestradiol
  622. >CYP1A2 and CYP3A4 are the major enzymes catalyzing the 2-hydroxylation of estradiol
  623. >2-Hydroxyestradiol has been found to increase prolactin secretion when administered intravenously to women.[6] It was noted that this could be due to 2-hydroxyestradiol binding to and antagonizing the D2 receptor
  624.  
  625. 015: 15q; CYP19A1 (13T;) Position: 15q21.1
  626. \https://academic.oup.com/jcem/article-lookup/doi/10.1210/jcem.83.4.4697
  627. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC333565/?page=1
  628. \https://academic.oup.com/humrep/article/25/12/3146/550945
  629. >Association of aromatase (TTTAn) repeat polymorphism length and the relationship between obesity and decreased sperm concentration [...] Men with high repeats had higher estradiol
  630.  
  631. 015b: 15q; CYP19A1 (TT;) Position: 51287401
  632. \https://www.ncbi.nlm.nih.gov/m/pubmed/16949385/
  633. >TT genotype was associated with [...] lower testosterone and higher E2 levels
  634. \https://www.snpedia.com/index.php/Rs936306
  635. -^
  636.  
  637. 015c: 15q; CYP19A1 (GG;) Position: 51266534
  638. \https://www.ncbi.nlm.nih.gov/m/pubmed/16949385/
  639. >AA genotype of the CYP 19 rs749292 [...] had lower testosterone and E2 levels but higher levels of sex hormone-binding globulin (SHBG)
  640. \https://www.snpedia.com/index.php/Rs749292
  641. -^
  642.  
  643. 015d: 15q; CYP19A1 (AA;) Position: 51237582
  644. \https://www.ncbi.nlm.nih.gov/m/pubmed/16949385/
  645. >lower SHBG levels among those with the AA genotype of the CYP 19 rs2414096
  646. \https://www.snpedia.com/index.php/Rs2414096
  647. -^
  648.  
  649. 015e: 15q; CYP19A1 (TT;) Position: 51210789
  650. \http://cebp.aacrjournals.org/content/18/5/1617.long
  651. >alleles [...] rs10046(T) [...] were associated with higher levels of estrogens
  652. \https://www.snpedia.com/index.php/Rs10046
  653. -^
  654.  
  655. 015f: 15q; CYP19A1 (TT;) Position: 51210789
  656. \http://cebp.aacrjournals.org/content/18/5/1617.long
  657. >rs727479(T) [...] were associated with higher levels of estrogens
  658. \https://www.snpedia.com/index.php/Rs727479
  659. -^
  660.  
  661. 015g: 15q; CYP19A1 (GG;) Position: 51210647
  662. \http://cebp.aacrjournals.org/content/18/5/1617.long
  663. >alleles [...] rs4646(G) were associated with higher levels of estrogens
  664. \https://www.snpedia.com/index.php/Rs4646
  665. -^
  666.  
  667. 015h: 15q; CYP19A1 (GG;) Position: 51236915
  668. \http://cebp.aacrjournals.org/content/18/5/1617.long
  669. >The Val80 (rs700518) G allele was found to be associated with elevated aromatase expression
  670. \https://www.snpedia.com/index.php/Rs700518
  671. -^
  672.  
  673. 015i: 15q; CYP19A1 (CC;) Position: 51321614
  674. \https://www.snpedia.com/index.php/Rs1004982
  675. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760732/
  676. >The risk of breast cancer with (but not without) proliferative fibrocystic conditions was increased among women homozygous for the minor allele of rs1004982 (C)
  677. -^
  678.  
  679. 015j: 15q; CYP19A1 (TT;) Position: 51287401
  680. \https://www.snpedia.com/index.php/Rs936306
  681. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760732/
  682. >The risk of breast cancer with (but not without) proliferative fibrocystic conditions was increased among women homozygous for the minor allele of [...] rs936306 (T)
  683. -^
  684.  
  685. 015k: 15q; CYP19A1 (CC;) Position: 51243825
  686. \https://www.snpedia.com/index.php/Rs4775936
  687. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760732/
  688. >The risk of breast cancer with (but not without) proliferative fibrocystic conditions was increased among women homozygous for the minor allele of [...] and rs4775936 (C)
  689. -^
  690.  
  691. 015l: 15q; CYP19A1 (GG;) Position: 51255741
  692. \https://www.ncbi.nlm.nih.gov/m/pubmed/20417295/
  693. >GG genotype at rs1062033 was associated with an increased risk of knee OA
  694. \https://www.snpedia.com/index.php/Rs1062033
  695. -^
  696.  
  697. 015m: 15q; CYP19A1 (CC;) Position: 51211017
  698. \https://www.ncbi.nlm.nih.gov/clinvar/variation/17815/
  699. \https://www.snpedia.com/index.php/Rs121434534
  700. \https://www.omim.org/entry/107910#0001
  701. >Aromatase deficiency [...] C-to-T transition
  702.  
  703. 015n: 15q; CYP19A1 (CC;) Position: 51211017
  704. \https://www.ncbi.nlm.nih.gov/clinvar/variation/17818/
  705. \https://www.snpedia.com/index.php/Rs121434536
  706. \https://omim.org/entry/107910#0004
  707. >Aromatase deficiency [...] C-to-T transition
  708.  
  709. 015o: 15q; CYP19A1 (GG;) Position: 51222349
  710. \https://www.ncbi.nlm.nih.gov/clinvar/variation/17826/
  711. \https://www.snpedia.com/index.php/Rs121434538
  712. \https://omim.org/entry/107910#0012
  713. >Aromatase deficiency [...] G-to-A transition
  714.  
  715. 015p: 15q; CYP19A1 (GG;) Position: 51231710
  716. \https://www.ncbi.nlm.nih.gov/m/pubmed/17216495/
  717. >Men carrying AA/AG genotypes in the rs12594287 SNP had a 30% reduced risk of having extreme low femoral neck BMD
  718. \https://www.snpedia.com/index.php/Rs12594287
  719. -^
  720.  
  721. 015q: 15q; CYP19A1 (CC;) Position: 51223154
  722. \https://www.ncbi.nlm.nih.gov/m/pubmed/17216495/
  723. >TT/TC genotypes in the rs16964201 SNP had a 40% reduced risk of having extreme low femoral neck BMD
  724. \https://www.snpedia.com/index.php/Rs16964201
  725. -^
  726.  
  727. 015r: 15q; CYP19A1 (CC;) Position: 51237900
  728. \https://www.ncbi.nlm.nih.gov/m/pubmed/17216495/
  729. >Men with TC/CC genotypes in the rs17703883 SNP had a 1.5 times higher risk of having extreme low femoral neck BMD
  730. \https://www.snpedia.com/index.php/Rs17703883
  731. -^
  732.  
  733. 015s: 15q; CYP19A1 (GG;) Position: 51302775
  734. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681277/table/T4/?report=objectonly
  735. >AA = E2(17.5pg/ml-/+6.2,) AG = E2(18.8pg/ml-/+6.1,) GG = E2(19.8pg/ml-/+6.2)
  736. \https://www.snpedia.com/index.php/Rs2470152
  737. -^
  738.  
  739. 015t: 15q; CYP19A1 (GG;) Position: 51314513
  740. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3751591
  741. >Ancestral Allele = T [...] Fwd = C/T, Rev = A/G, C-A/T-G, A=C/G=T, so Ancestral Allele = G(Fwd)/T(Rev)
  742. \https://www.snpedia.com/index.php/Rs3751591
  743. \http://www.sciencedirect.com/science/article/pii/S000292971000594X#!
  744. >Table 1. Sixty-Four Loci Showing Significant Evidence for Association with Adult Height [...] rs3751591, Effect allele: A, Effect: +0.25
  745. -^
  746.  
  747. 015u: 15q; CYP19A1 (CC;) Position: 51243825
  748. \https://www.ncbi.nlm.nih.gov/m/pubmed/19064562/
  749. >breast cancer with (but not without) proliferative fibrocystic conditions was increased among women homozygous for the minor allele of [...] rs4775936 (C) relative to those homozygous for the major allele
  750. \https://www.snpedia.com/index.php/Rs4775936
  751. -^
  752.  
  753. 015v: 15q; CYP19A1 (CC;) Position: 51215771
  754. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=700519
  755. \https://www.snpedia.com/index.php/Rs700519
  756. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613759/table/T3/?report=objectonly
  757. \rs700519 CC = Estradiol(9.3-11.1,) CT/TT = Estradiol(8.6-11.1)
  758. -^
  759.  
  760. 015w: 15q; CYP19A1 (AA;) Position: 51242350
  761. \https://www.ncbi.nlm.nih.gov/m/pubmed/19124504/
  762. \A alleles of rs749292 and rs727479) have been associated with a 10% to 20% increase in circulating estrogen levels
  763. \https://www.snpedia.com/index.php/Rs727479
  764. -^
  765.  
  766. 015x: 15q; CYP19A1 (AA;) Position: 51266534
  767. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812905/table/T4/?report=objectonly
  768. >rs749292 GG = Estradiol(98.0-113.1,) GA = Estradiol(99.9-115.1,) AA = Estradiol(104.9-121.7)
  769. \https://www.snpedia.com/index.php/Rs749292
  770. -^
  771.  
  772. 016: 10q; CYP2E1 (CC;) Position: 133536297
  773. \https://www.snpedia.com/index.php/Rs1329149
  774. \https://www.ncbi.nlm.nih.gov/m/pubmed/19706845/
  775. >A novel polymorphism rs1329149 of CYP2E1 [...] are associated with colorectal cancer [...] The adjusted OR was [...] 4.04 for the rs1329149 T/T genotype
  776. -^
  777.  
  778. 016b: 10q; CYP2E1 (CC;) Position: 133537633
  779. \https://www.snpedia.com/index.php/Rs2070676
  780. \https://www.ncbi.nlm.nih.gov/m/pubmed/19381774/
  781. >We found an association between allele and genotype frequencies of the C/G polymorphism at intron 7 (rs2070676) of this gene and PD(Parkinsons disease) (P value of 0.026 and 0.027, respectively
  782. -^
  783.  
  784. 017: 7q; CYP3A (GG;) Position: 99784473
  785. \https://www.snpedia.com/index.php/Rs2740574
  786. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165281/
  787. >prostate cancer (PCa [...] Recent papers have reported that men with a Gleason score of >7 had lower intraprostatic DHT than men with a Gleason score of <6, suggesting that a low-androgen microenvironment predisposes to development or progression for high-grade PCa or CRPC
  788. >Note: Hypoactive DHT synthesis will lead to excess T. If CYP3A4 metabolizes T and estradiol into 2-Hydroxyestradiol, and 17b-HSD synthesis is hypoactive leading to a buildup of Estrone, than a CYP3A4 allele that leads to prostate cancer will also lead to hypoactive 2-Hydroxyestradiol synthesis due to a lack of Estradiol substrate and impaired CYP3A4 function.
  789. \http://cebp.aacrjournals.org/content/8/10/901.long
  790. >The G variant was not found in the Chinese or Japanese populations
  791. >In this case, being homozygous for the CYP3A4 variant appeared to increase the risk of presenting with high grade/stage
  792. >A comparison of men with AG to AAand GG to AA showed a slight increasing trend for Gleason grade
  793. >We report consistent positive associations between the CYP3A4 variant and clinical characteristics in African-American men with prostate cancer
  794. \https://www.omim.org/entry/124010#39
  795. >They referred to the polymorphism as CYP3A4-V (124010.0001
  796. >The CYP3A4*1B allele (124010.0001) may decrease the oxidative deactivation of testosterone (Rebbeck et al., 1998). African Americans have the highest documented rates of prostate cancer in the world
  797. >The overlap between these blocks in these 2 groups contained only 2 of the investigated 26 SNPs, and 1 of them was the CYP3A4*1B allele. The region centromeric of CYP3A4*1B on 7q exhibited high haplotype homozygosity in European Caucasians as opposed to African Americans. CYP3A4*1B showed a moderate effect on CYP3A4 mRNA and protein expression
  798. \https://en.wikipedia.org/wiki/2-Hydroxyestradiol
  799. >CYP1A2 and CYP3A4 are the major enzymes catalyzing the 2-hydroxylation of estradiol
  800. >2-Hydroxyestradiol has been found to increase prolactin secretion when administered intravenously to women.[6] It was noted that this could be due to 2-hydroxyestradiol binding to and antagonizing the D2 receptor
  801.  
  802. 017b: 7q: CYP3A4 (TT;) Position: 99758183
  803. \https://www.snpedia.com/index.php/Rs67666821
  804. \https://www.ncbi.nlm.nih.gov/m/pubmed/16580902/
  805. >Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity
  806. \https://www.pharmgkb.org/haplotype/PA165819244
  807. >CYP3A4*20
  808. >Location: rs67666821
  809. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=67666821
  810. >Ancestral allele = G, Derived allele = -/T(Fwd)
  811.  
  812. D
  813.  
  814. 001: 13q; DAOA (AA;) Position: 105487313
  815. \https://www.snpedia.com/index.php/Rs947267
  816. \https://www.ncbi.nlm.nih.gov/m/pubmed/17293043/
  817. >Our findings showed that the SNP rs947267 was significantly associated with schizophrenia [...] in particular those formed by the A allele of rs947267
  818. -^
  819.  
  820. 001b: 13q; DAOA (AA;) Position: 105467097
  821. \https://www.snpedia.com/index.php/Rs2391191
  822. \https://www.ncbi.nlm.nih.gov/m/pubmed/19482054/
  823. >Two haplotypes G-A of M12 (rs3916965)-M15 (rs2391191) [...] also showed associations with methamphetamine psychosis
  824. -^
  825.  
  826. 001c: 13q; DAOA (AA;) Position: 105484383
  827. \https://www.snpedia.com/index.php/Rs7139958
  828. \https://www.ncbi.nlm.nih.gov/m/pubmed/22122005/
  829. >rs7139958 AA [...] rs7139958 A [...] genotypes were associated with higher scores on the PANSS positive subscale among patients with schizophrenia, possibly reflecting their greater susceptibility to the development of more severe positive symptoms
  830. -^
  831.  
  832. 001d: 13q; DAOA (AA;) Position: 105489886
  833. \https://www.snpedia.com/index.php/Rs778294
  834. \https://www.ncbi.nlm.nih.gov/m/pubmed/19763662/
  835. >for rs778294, 50% of probands with the AA genotype, but only 22% of probands with a GG or GA genotype progressed to psychosis
  836. -^
  837.  
  838. 001e: 13q; DAOA (TT;) Position: 105486017
  839. \https://www.snpedia.com/index.php/Rs9558571
  840. \https://www.ncbi.nlm.nih.gov/m/pubmed/22122005/
  841. >rs9558571 TT [...] rs9558571 T genotypes were associated with higher scores on the PANSS positive subscale among patients with schizophrenia, possibly reflecting their greater susceptibility to the development of more severe positive symptoms
  842. -^
  843.  
  844. 002: 9q; DBH (CC;) Position: 133658547
  845. \https://www.snpedia.com/index.php/Rs129882
  846. \https://www.ncbi.nlm.nih.gov/m/pubmed/25975715/
  847. >Specifically, the C allele of the ADHD-associated rs129882 SNP produced a 2-fold decrease [...] in luciferase activity [...] Reduced DBH expression would be consistent with decreased conversion of dopamine to noradrenaline
  848. -^
  849.  
  850. 002b: 9q; DBH (TT;) Position: 133635393
  851. \https://www.snpedia.com/index.php/Rs1611115
  852. \https://www.ncbi.nlm.nih.gov/m/pubmed/17625104/
  853. >The T allele associated with lower serum DBH in both groups [...] −1021C->T polymorphism of DBH (rs1611115)
  854. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728391/table/T3/?report=objectonly
  855. >rs1611115 T allele frequency = Schizophrenics(0.774,) Controls(0.733)
  856. \https://www.nature.com/articles/5201838
  857. >we also examined the association of rs161115 to pDβH [...] Subjects with CC had the highest square-root plasma DβH activity (N=36, 4.56±1.65), followed by subjects with CT (N=14, 3.96-/+1.61) and TT (N=5, 1.35-/+0.60)
  858. -^
  859.  
  860. 002c: 9q; DBH (GG;) Position: 133638697
  861. \https://www.snpedia.com/index.php/Rs2007153
  862. \https://www.ncbi.nlm.nih.gov/pubmed/19673036?dopt=Abstract
  863. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728391/table/T3/?report=objectonly
  864. >rs2007153 G allele frequency = Schizophrenics(0.658,) Controls(0.470)
  865. -^
  866.  
  867. 002d: 9q; DBH (CC;) Position: 133650175
  868. \https://www.snpedia.com/index.php/Rs2283123
  869. \https://www.ncbi.nlm.nih.gov/pubmed/19673036?dopt=Abstract
  870. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728391/table/T3/?report=objectonly
  871. >rs2283123 T allele frequency = Schizoprenics(0.020,) Controls(0.063)
  872.  
  873. 002e: 9q; DBH (TT;) Position: 133644512
  874. \https://www.snpedia.com/index.php/Rs2519152
  875. \http://www.nature.com/ejhg/journal/v15/n8/fig_tab/5201838t1.html#figure-title
  876. \https://www.nature.com/articles/5201838/tables/1
  877. >rs2519152 plasma DBH activity = CC(5.47-/+1.83,) CT(5.33-/+1.87,) TT(3.85-/+2.05)
  878. -^
  879.  
  880. 002g: 9q; DBH (AA;) Position: 133647854
  881. \https://www.snpedia.com/index.php/Rs267606761
  882. \https://www.ncbi.nlm.nih.gov/clinvar/?term=rs267606761
  883. \https://www.omim.org/entry/609312#0004
  884. >In a patient with dopamine beta-hydroxylase deficiency [...] identified [...] a 259G-A transition in exon 1, resulting in a val87-to-met (V87M) substitution, and a 991G-A transition
  885.  
  886. 002h: 9q; DBH (CC;) Position: 133636712
  887. \https://www.snpedia.com/index.php/Rs74853476
  888. \https://www.ncbi.nlm.nih.gov/clinvar/variation/1750/
  889. \https://www.omim.org/entry/609312#0002
  890. \2 unrelated patients with dopamine beta-hydroxylase deficiency [...] identified a heterozygous T-to-C transition
  891. -^
  892.  
  893. 002i: 9q; DBH (AA;) Position: 133636712
  894. \https://www.snpedia.com/index.php/Rs75215331
  895. \https://www.ncbi.nlm.nih.gov/clinvar/variation/217765/
  896. \https://www.ncbi.nlm.nih.gov/clinvar/RCV000201828/
  897. >NM_000787.3:c.1085C>A [...] NP_000778.3:p.Ala362Glu [...] Protein change:
  898. A348E [...] dbSNP: 75215331
  899. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059068/?report=reader#!po=49.0741
  900. >Strikingly, media from all three mutant forms of DBH showed [...] undetectable (in the case of A348E [...] amounts of proteins
  901.  
  902. -^
  903.  
  904. 003: 18q; DCC (AA;) Position: 53530928
  905. \https://www.snpedia.com/index.php/Rs227095
  906. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2270954
  907. >MAF = A
  908. \https://www.ncbi.nlm.nih.gov/m/pubmed/22418395/
  909. >rs2270954 [...] schizophrenia; patients were less likely to be heterozygous at this locus and more likely to be homozygous for the minor allele
  910. -^
  911.  
  912. 004: 1q; DISC1 (AA;) Position: 231694549
  913. \https://www.snpedia.com/index.php/Rs3738401
  914. \https://www.ncbi.nlm.nih.gov/m/pubmed/17673452/
  915. >A of [...] rs3738401 at the 5' end of DISC1 was over-transmitted to males with psychotic disorder
  916. -^
  917.  
  918. 004b: 1q; DISC1 (CC;) Position: 231818355
  919. \https://www.snpedia.com/index.php/Rs6675281
  920. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736903/
  921. >Schizophrenia risk-associated polymorphisms [...] rs6675281 (Leu607Phe) [...] on the expression of Δ7Δ8 mRNA [...] T (Phe) carriers (the 3 T/T subjects combined and the C/T subjects) showed significantly higher expression than C/C (Leu/Leu) individuals [by 22%
  922. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736903/figure/F2/?report=objectonly
  923. >Δ7Δ8 mRNA levels = Controls(90,) Schizophrenics(130)
  924. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6675281
  925. >CTC [Leucine] -> TTC [Phenylalanine]
  926.  
  927. 004c: 1q; DISC1 (TT;) Position: 231632793
  928. \https://www.snpedia.com/index.php/Rs751229
  929. \https://www.ncbi.nlm.nih.gov/m/pubmed/17673452/
  930. >T [...] of rs751229 [...] at the 5' end of DISC1 was over-transmitted to males with psychotic disorder
  931. -^
  932.  
  933. 004d: 1q; DISC1 (TT;) Position: 231931311
  934. \https://www.snpedia.com/index.php/Rs821577
  935. \https://www.ncbi.nlm.nih.gov/m/pubmed/19188535/
  936. >minor allele of rs821577 was significantly associated with higher scores on social and physical anhedonia
  937. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=821577
  938. >MAF = T
  939. -^
  940.  
  941. 005: 1q; DNM3 (AA;) Position: 1723465448
  942. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1011731
  943. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  944. >aEffect Allele: WHR increasing allele on the forward strand;
  945. >DNM3, EA = G
  946.  
  947. 005b: 1q; DNM3 (TT;) Position: 172084147
  948. \https://www.snpedia.com/index.php/Rs17346452
  949. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955183/bin/NIHMS225625-supplement-1.doc
  950. \Hundreds of variants clustered in genomic loci and biological pathways affect human height [...] rs17346452 Effect Allele = T(-0.038)
  951. -^
  952.  
  953. 006: 5q; DRD1 (CC;) Position: 175443899
  954. \https://www.snpedia.com/index.php/Rs265981
  955. \https://www.ncbi.nlm.nih.gov/m/pubmed/18205172/
  956. >associations of the rs265981-C [...] with more severe problems in social interaction, greater difficulties with nonverbal communication and increased stereotypies
  957. -^
  958.  
  959. 006b: 5q; DRD1 (AA;) Position: 175443147
  960. \https://www.snpedia.com/index.php/Rs4532
  961. \https://www.ncbi.nlm.nih.gov/m/pubmed/18205172/
  962. >associations of [...] rs4532-A [...] alleles [...] with more severe problems in social interaction, greater difficulties with nonverbal communication and increased stereotypies
  963. -^
  964.  
  965. 006c: 5q; DRD1 (TT;) Position: 175441697
  966. \https://www.snpedia.com/index.php/Rs686
  967. \https://www.ncbi.nlm.nih.gov/m/pubmed/18205172/
  968. >associations of [...] rs686-T alleles [...] with more severe problems in social interaction, greater difficulties with nonverbal communication and increased stereotypies
  969.  
  970. 007: 11q; DRD2 (CC;) Position: 113425552
  971. \https://www.snpedia.com/index.php/Rs1079598
  972. \https://www.ncbi.nlm.nih.gov/m/pubmed/21247255/
  973. >The DRD2 rs1079598 CC genotype was overrepresented in aggressive children compared to controls
  974. _^
  975.  
  976. 007b: 11q; DRD2 (CC;) Position: 113447023
  977. \https://www.snpedia.com/index.php/Rs17601612
  978. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=17601612
  979. >MAF = C
  980. \https://www.ncbi.nlm.nih.gov/pubmed/25184405?dopt=Abstract
  981. >Reports of higher subclinical psychotic experiences were associated with DRD2 SNPs rs17601612
  982. -^
  983.  
  984. 007c: 11q; DRD2 (-;-;) Position: 113475529
  985. \https://www.snpedia.com/index.php/Rs1799732
  986. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1799732
  987. \https://www.ncbi.nlm.nih.gov/pubmed/19547807?dopt=Abstract
  988. >Thus the -141C Ins/Del polymorphism of the DRD2 gene (allele Ins) was associated to the SCZ phenotype
  989. \https://www.ncbi.nlm.nih.gov/pubmed/20146828?dopt=Abstract
  990. >significant association of -141C Ins allele [...] of DRD2 with alcohol dependence
  991. \http://www.sciencedirect.com/topics/neuroscience/dopamine-hypothesis-of-schizophrenia
  992. >studies have shown an increased density of the dopamine D2 receptor in postmortem brain tissue of schizophrenia sufferers
  993. \http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010670
  994. >Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals [...] The results show a negative correlation between divergent thinking scores and D2 density in the thalamus [...] We suggest that decreased D2 receptor densities in the thalamus lower thalamic gating thresholds, thus increasing thalamocortical information flow. In healthy individuals, who do not suffer from the detrimental effects of psychiatric disease, this may increase performance on divergent thinking tests
  995. -^
  996.  
  997. 007d: 11q; DRD2 (CC;) Position: 113412755
  998. \https://www.snpedia.com/index.php/Rs6275
  999. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6275
  1000. \https://www.ncbi.nlm.nih.gov/pubmed/18477981?dopt=Abstract
  1001. >association study of the DRD2 gene C939T polymorphism and schizophrenia [...] the frequency of the TT genotype being higher in patients compared to the controls
  1002. -^
  1003.  
  1004. 007e: 11q; DRD2 (TT;) Position: 113412737
  1005. \https://www.snpedia.com/index.php/Rs6277
  1006. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6277
  1007. \https://www.ncbi.nlm.nih.gov/pubmed/18255274?dopt=Abstract
  1008. >Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population [...] Frequency of the C allele, corresponding to a normal wild-type level of expression, was higher in patients compared to controls, and that of the T allele was lower
  1009. -^
  1010.  
  1011. 008: 3q; DRD3 (AA;) Position: 114157428
  1012. \https://www.snpedia.com/index.php/Rs167771
  1013. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324694/
  1014. >Insistence on Sameness (IS) [...] Individuals carrying the AA variant of the rs167771 SNP scored significantly higher on the IS-factor
  1015. \https://www.nature.com/articles/tpj200926/tables/4
  1016. >A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms
  1017. >DRD3 rs16771 Associated allele = G, G Frequency = Cases(0.45,) Controls(0.2)
  1018. -^
  1019.  
  1020. 008b: 3q; DRD3 (AA;) Position: 114171968
  1021. \https://www.snpedia.com/index.php/Rs6280
  1022. \https://www.ncbi.nlm.nih.gov/m/pubmed/18320559/
  1023. >The rate of positive symptom remission, defined as all PANSS positive items less than three (minimal or absent symptoms) was also tested for association with ser-9-gly genotypes [...] Approxi- mately 39% of patients with the gly/gly genotype were remitters compared with 14% patients with ser/ser or ser/gly genotypes
  1024. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6280
  1025. >G(Gly) -> A(Ser)
  1026. -^
  1027.  
  1028. 009: 11q; DRD4 (CC;) Position: 641191
  1029. \https://www.snpedia.com/index.php/Rs11246226
  1030. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728391/table/T3/?report=objectonly
  1031. >Association of Tagging Single Nucleotide Polymorphisms on 8 Candidate Genes in Dopaminergic Pathway with Schizophrenia in Croatian Population
  1032. >Alleles = (Major/minor)A/C, C Frequency = Controls(0.183,) Cases(0.078)
  1033. -^
  1034.  
  1035. 009b: 11q; DRD4 (CC;) Position: 636784
  1036. \https://www.snpedia.com/index.php/Rs1800955
  1037. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1800955
  1038. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1705471/table/Tab1/?report=objectonly
  1039. >Association and synergistic interaction between promoter variants of the DRD4 gene in Japanese schizophrenics
  1040. >rs1800955 Frequency = Controls(CC=0.19, CT=0.48, TT=0.34,) Cases(CC=0.16, CT=0.50, TT=0.34)
  1041. -^
  1042.  
  1043. 010: 6q; DTNBP1 (TT;) Position: 15656839
  1044. \https://www.snpedia.com/index.php/Rs1018381
  1045. \https://www.ncbi.nlm.nih.gov/m/pubmed/21130223/
  1046. >rs1018381 [...] suggesting that the minor allele carriers of these SNPs had lower cognitive ability scores than the major allele homozygotes
  1047. \https://www.ncbi.nlm.nih.gov/m/pubmed/19497374/
  1048. >heterozygous risk-allele carriers (T/C) and homozygous non-carriers (C/C [...] Stronger right hemispherical brain activation in anterior cingulate gyrus (BA 24), superior (BA 22, 38) and middle (BA 21) temporal gyrus was observed in the carriers compared to non-carriers
  1049. \https://en.wikipedia.org/wiki/Dysbindin
  1050. >schizophrenic patients carrying the high-risk haplotype demonstrated visual processing deficits [...] damping down the DTNBP1 expression led to an increase in cell surface dopamine D2-receptor levels
  1051. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33999/
  1052. >increase in the level of dopamine as well as an increase in the number of D2 receptors in schizophrenia
  1053. -^
  1054.  
  1055. 010b: 6q; DTNBP1 (CC;) Position: 15572843
  1056. \https://www.snpedia.com/index.php/Rs742105
  1057. \https://www.ncbi.nlm.nih.gov/m/pubmed/19369910/
  1058. >Patients with [...] allele T of marker rs742105 (P1333) have better response to clozapine
  1059.  
  1060. 010c: 6q; DTNBP1 (CC;) Position: 15650901
  1061. \https://www.snpedia.com/index.php/Rs760761
  1062. \https://www.ncbi.nlm.nih.gov/m/pubmed/19800201/
  1063. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783814/table/T1/?report=objectonly
  1064. >DTNBP [...] is associated with schizophrenia [...] rs760761 Major allele = C, Frequency(of C) = Cases(0.809,) Controls(0.742)
  1065. -^
  1066.  
  1067. 010d: 6q; DTNBP1 (CC;) Position: 15544505
  1068. \https://www.snpedia.com/index.php/Rs9370822
  1069. \https://www.ncbi.nlm.nih.gov/m/pubmed/20615671/
  1070. >Homozygotes for the C allele of rs9370822 were more than two and a half times as likely to have schizophrenia
  1071. -^
  1072.  
  1073. 011: 18q; DYN (CC;) Position: 49081890
  1074. \https://www.snpedia.com/index.php/Rs833497
  1075. \https://www.nature.com/articles/jhg201072/tables/1
  1076. >rs833497 CC = Affected(0.13,) Controls(0.10,) TC = Affected(0.45,) Controls(0.40,) TT = Affected(0.42,) Controls(0.50)
  1077.  
  1078. E
  1079.  
  1080. 001: 2q; EDAR (CC;) Position: 108897145
  1081. \https://www.snpedia.com/index.php/Rs3827760
  1082. \https://omim.org/entry/604095#0011
  1083. >HAIR MORPHOLOGY 1, HAIR THICKNESS [...] C allele was present at a frequency of 87.6% in 180 Chinese and Japanese samples, compared to 0% in 120 European and African samples [...] A further study [...] showed a significant association of the 1540T/C SNP with cross-sectional area of hairs [...] a follow-up study, Fujimoto et al. (2008) found a significant association between 1540C and increased hair cross-sectional area [...] of a possible association between the T1540C polymorphism and shovel-shaped incisors, see 147400
  1084. \https://omim.org/entry/147400
  1085. >Kimura et al. (2009) measured crown diameter and tooth-shoveling grade in 102 individuals from around Tokyo and 100 from the Sakishima Islands, then analyzed the correlation between dental traits and a T1540C polymorphism (rs3827760) in the EDAR gene (604095.0011 [...] EDAR 1540C alleles in an individual strongly correlated with the tooth-shoveling [...] the effect of the allele was additive and explained 18.9% of total variance in shoveling [...] 1540C significantly affected overall tooth size
  1086.  
  1087. 002: Xq; EDA2R (CC;) Position: 66605144
  1088. \https://www.snpedia.com/index.php/Rs1385699
  1089. \https://www.ncbi.nlm.nih.gov/m/pubmed/18385763/
  1090. >rs1385699 was revealed to have the strongest association [...] (T-allele kinship-corrected frequencies cases=0.92, controls=0.7
  1091. -^
  1092.  
  1093. 003: 2q; EN1 (CC;) Position: 119545994
  1094. \http://www.pdgene.org/view?poly=rs11692564
  1095. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755714/table/T2/
  1096. >We identified a low-frequency non-coding variant near a novel locus, EN1 [...] rs11692564[T], MAF = 1.7% [...] which was also associated with a decreased risk of fracture (OR = 0.85 [...] an En1Cre/flox mouse model, we observed that conditional loss of En1 results in low bone mass
  1097. \http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538659/
  1098. \We propose that these high levels of En1 serve to drive the formation of eccrine glands at the expense of hair follicles
  1099. \http://www.nature.com/nature/journal/v526/n7571/abs/nature14878.html
  1100. \Using an En1cre/flox mouse model, we observed that conditional loss of En1 results in low bone mass, probably as a consequence of high bone turnover
  1101. \EN1+ = BMD+, Eccrine Glands+, Hair follicles-
  1102. \EN1- = BMD-, Eccrine Glands-, Hair follicles+
  1103.  
  1104. 003b: 2q; EN1 (GG;) Position: 118855868
  1105. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=188303909
  1106. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755714/table/T2/
  1107. >Variant rs188303909 was in moderate LD with rs11692564
  1108.  
  1109. 003c: 2q; EN1 (TT;) Position: 118772253
  1110. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=55983207
  1111. >MAF = C
  1112. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755714/table/T2/
  1113. >We also identified an additional association signal, arising from rs55983207 (MAF = 4%), 17 kb downstream of rs11692564 (r2 = 0.001) to be associated with femoral neck BMD
  1114.  
  1115. 003d: 2q; EN1 (GG;) Position: 118397296
  1116. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6542457
  1117. >MAF = C
  1118. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755714/table/T2/
  1119. >we also observed two additional novel genome-wide significant variants for lumbar spine BMD near EN1, rs6542457 (MAF = 6.7%
  1120.  
  1121. 004: 2q; EPAS1 (GG;) Position: 46329206
  1122. \https://www.snpedia.com/index.php/Rs13419896
  1123. \https://www.ncbi.nlm.nih.gov/m/pubmed/25792003/
  1124. >frequencies of the G allele of EPAS1 SNP rs13419896 were significantly higher in the HAPC group than in the control group
  1125.  
  1126. 004b: 2q; EPAS1 (AA;) Position: 46348249
  1127. \https://www.snpedia.com/index.php/Rs4953354
  1128. \https://www.ncbi.nlm.nih.gov/m/pubmed/25792003/
  1129. >A alleles of rs12619696 and rs4953354 were prevalent in the HAPC group
  1130.  
  1131. 004c: 2q; EPAS1 (AA;) Position: 46463303
  1132. \https://www.snpedia.com/index.php/Rs12619696
  1133. \https://www.ncbi.nlm.nih.gov/m/pubmed/25792003/
  1134. >A alleles of rs12619696 and rs4953354 were prevalent in the HAPC group
  1135.  
  1136. 004: 2q; ERBB4 (AA;) Position: 211951364
  1137. \https://www.snpedia.com/index.php/Rs839523
  1138. \https://www.ncbi.nlm.nih.gov/m/pubmed/22115776/
  1139. >Three common ERBB4 single nucleotide polymorphisms that were previously associated with schizophrenia and impaired frontotemporal-related information processing (rs7598440, rs839523, and rs707284 [...] GGG haplotype homozygotes were associated with "protective" effects on VWM performance and PE(Psychotic experiences,) AAA "risk" haplotype carriers were associated with worse VWM performance and simultaneously exhibited significantly elevated PE
  1140.  
  1141. 004b: 2q; ERBB4 (AA;) Position: 211974321
  1142. \https://www.snpedia.com/index.php/Rs707284
  1143. \https://www.ncbi.nlm.nih.gov/m/pubmed/22115776/
  1144. >Three common ERBB4 single nucleotide polymorphisms that were previously associated with schizophrenia and impaired frontotemporal-related information processing (rs7598440, rs839523, and rs707284 [...] GGG haplotype homozygotes were associated with "protective" effects on VWM performance and PE(Psychotic experiences,) AAA "risk" haplotype carriers were associated with worse VWM performance and simultaneously exhibited significantly elevated PE
  1145.  
  1146. 004c: 2q; ERBB4 (AA;) Position: 211928473
  1147. \https://www.snpedia.com/index.php/Rs7598440
  1148. \https://www.ncbi.nlm.nih.gov/m/pubmed/22115776/
  1149. >Three common ERBB4 single nucleotide polymorphisms that were previously associated with schizophrenia and impaired frontotemporal-related information processing (rs7598440, rs839523, and rs707284 [...] GGG haplotype homozygotes were associated with "protective" effects on VWM performance and PE(Psychotic experiences,) AAA "risk" haplotype carriers were associated with worse VWM performance and simultaneously exhibited significantly elevated PE
  1150.  
  1151. 005: 6q; ESR1 (AA;) Position: 151975965
  1152. \https://www.snpedia.com/index.php/Rs2179922
  1153. \https://www.ncbi.nlm.nih.gov/m/pubmed/18350145/
  1154. >Homozygote carriers of the G-allele of the SNP rs2179922 were on average 0.90 cm taller
  1155.  
  1156. 005b: 6q; ESR1 (TT;) Position: 152061176
  1157. \https://www.snpedia.com/index.php/Rs2273206
  1158. \https://www.ncbi.nlm.nih.gov/m/pubmed/18424448/
  1159. >The T allele of another intron 6 SNP was part of a 3' haplotype less common in schizophrenia [rs2273206(T), rs2273207(G), rs2228480(G)
  1160.  
  1161. 005c: 6q; ESR1 (GG;) Position: 152061190
  1162. \https://www.snpedia.com/index.php/Rs2273207
  1163. \https://www.ncbi.nlm.nih.gov/m/pubmed/18424448/
  1164. >The T allele of another intron 6 SNP was part of a 3' haplotype less common in schizophrenia [rs2273206(T), rs2273207(G), rs2228480(G)
  1165.  
  1166. 005d: 6q; ESR1 (GG;) Position: 152098960
  1167. \https://www.snpedia.com/index.php/Rs2228480
  1168. \https://www.ncbi.nlm.nih.gov/m/pubmed/18424448/
  1169. >The T allele of another intron 6 SNP was part of a 3' haplotype less common in schizophrenia [rs2273206(T), rs2273207(G), rs2228480(G)
  1170. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276716/
  1171. >Dopamine Inhibits Basal Prolactin Release
  1172. \https://www.ncbi.nlm.nih.gov/m/pubmed/7449733/
  1173. >estradiol benzoate (25 microgram/kg, sc) daily for 5 days resulted in a marked elevation of the serum PRL
  1174. \https://www.mayoclinic.org/diseases-conditions/prolactinoma/symptoms-causes/syc-20376958
  1175. >The major effect is decreased levels of some sex hormones — estrogen in women and testosterone in men
  1176. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793919/#!po=26.0417
  1177. >The subjective effects of stimulant drugs vary across the menstrual cycle, with subjective reports from women in the follicular phase, when estradiol is low, being more similar to reports from men, while rising estradiol during the luteal phase, as well as the administration of exogenous estradiol, enhances the subjective effects of stimulants like cocaine and amphetamine [...] In the striatum and NAc, estradiol is able to acutely enhance DA signaling in females but not males
  1178. \http://www.tandfonline.com/doi/pdf/10.5455/bcp.20141212113905
  1179. >Negative symptom scores in the group with hyperprolactinemia were significantly higher than in the non-hyperprolactinemic group
  1180. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848766/
  1181. \male patients had more negative symptoms
  1182. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775856/
  1183. \Negative symptoms were the most common in male patients
  1184. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908169/
  1185. >lisdexamfetamine (LDX), a pro-drug of amphetamine licensed for use in ADHD, has been investigated for its possible treatment of negative symptoms in schizophrenia. Favorable results were published based on an open-label, randomized withdrawal phase trial demonstrating improvement in negative symptoms with LDX
  1186. \https://www.ncbi.nlm.nih.gov/m/pubmed/23756608/
  1187. >In adults with clinically stable schizophrenia, open-label LDX appeared to be associated with significant improvements in negative symptoms without positive symptom worsening
  1188. >Dopamine+ = Prolactin-, Estrogen+ = Prolactin+/Dopamine+
  1189. >Male = Prolactin+, Female = Prolactin-, and the elevated striatum and NAc DA signally caused by estridiol is likely the cause. Elevated DA in females also seems to reduce negative symptoms, based on efficacy of DA agonists to improve negative symtoms. If elevated DA causes schizophrenia, than an ESR1 allele with positive correlation for the disease entails DA- as DA agonists are protective against negative symptoms which are likely the basis for the increased rate of schizophrenia diagnosis among males. If decreased DA causes schizophrenia, than an ESR1 allele with positive correlation for the disease entails DA- as well - which contradicts the observed decrease in negative symptoms in females, who exhibit DA+. Therefore, a Schizophrenia+ ESR1 allele = Estrogen-, or;
  1190. >If Estrogen+ = Schizo- and Negative-, than Schizo+ = Negative+,
  1191. >If DA+ = Negative-, than Estrogen+ = Negative-,
  1192. >If Estrogen+ = Negative-, than Estrogen+ = DA+,
  1193. >Than Estrogen- = DA- = Schizo+ = Male+/Female-
  1194. >Therefore DA+ = Male-/Female+.
  1195.  
  1196. 005d: 6q; ESR1 (CC;) Position: 151949537
  1197. \https://www.snpedia.com/index.php/Rs3020314
  1198. \https://www.ncbi.nlm.nih.gov/m/pubmed/18636124/
  1199. \rs3020314 homozygous variant IVS4+5029CC genotype was associated with a 58% reduced risk of FL (follicular lymphoma)
  1200. \https://www.jcpsp.pk/archive/2009/Apr2009/14.pdf
  1201. >25-year-old female having asymptomatic edema of unilateral leg was provisionally diagnosed as a case of psoas abscess. Later, she turned out to be a case of non-Hodgkin’s lymphoma [...] She had diffuse ache in left lower limb, noticed swelling of left foot, which gradually progressed, proximally involving calf, thigh and groin
  1202.  
  1203. 005e: 6q; ESR1 (AA;) Position: 151951263
  1204. \https://www.snpedia.com/index.php/Rs3020377
  1205. \https://www.ncbi.nlm.nih.gov/m/pubmed/25218601/
  1206. >Among individuals with the COMT val allele, those with 2 copies of the ESR1 rs3020377 minor A allele exhibit reduced COMT activity, increased bodily pain, and poorer self-reported health
  1207.  
  1208. 005f: 6q; ESR1 (TT;) Position: 151959418
  1209. \https://www.snpedia.com/index.php/Rs3798759
  1210. \https://www.ncbi.nlm.nih.gov/m/pubmed/23450473/
  1211. >Single factor analysis stratified by sex also found that frequencies of rs3798759 GG and TG genotypes and G allele were significantly higher in female schizophrenia patients
  1212.  
  1213. 005g: 6q; ESR1 (AA;) Position: 151996005
  1214. \https://www.snpedia.com/index.php/Rs7757956
  1215. \https://www.ncbi.nlm.nih.gov/m/pubmed/17105837/
  1216. >For rs7757956, the difference in total body less head ABMC in late puberty was 50% less in individuals homozygous or heterozygous for the A allele
  1217.  
  1218. 005h: 6q; ESR1 (AA;) Position: 151842246
  1219. \https://www.snpedia.com/index.php/Rs9340799
  1220. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613912/
  1221. >rs9340799 were associated with endometrial cancer risk so that subjects homozygous for the rarer alleles [...] were at decreased risk as compared to homozygotes for the most common allele
  1222. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613912/table/T6/?report=objectonly
  1223.  
  1224. F
  1225.  
  1226. 001a: 15q; FBN1 (CC;) Position: 48428423
  1227. \https://www.snpedia.com/index.php/Rs137854457
  1228. \https://www.ncbi.nlm.nih.gov/clinvar/?term=rs137854457
  1229. >G[Cys] ->C[Ser]
  1230. \https://www.omim.org/entry/134797#0002
  1231. >MARFAN SYNDROME, MILD VARIABLE [...] Some affected adults were unaware of their status before the molecular diagnosis [...] cysteine-to-serine substitution at codon 2307 (C2307S) in an EGF-like motif from one fibrillin allele
  1232. -^
  1233.  
  1234. 001b: 15q; FBN1 (AA;) Position: 48425483
  1235. \https://www.snpedia.com/index.php/Rs137854464
  1236. \https://www.omim.org/entry/134797#0015
  1237. >the phenotype also included 'some skeletal manifestations, but no symptoms at all in the cardiovascular system
  1238. >mutation was detected in the DNA of all subjects with dislocated lenses, as well as in the DNA of 3 other members of the family with only skeletal manifestations
  1239. >In a 4-generation family with predominant ectopia lentis and only mild skeletal features of the Marfan syndrome but no sign of cardiovascular abnormality [...] found a G-to-A transition at nucleotide 7339
  1240.  
  1241. 001c: 15q; FBN1 (TT;) Position: 48600217
  1242. \https://www.snpedia.com/index.php/Rs137854467
  1243. \https://www.omim.org/entry/134797#0018
  1244. >proband was 21 years old when he was referred to a rheumatologist because of pain in the hands during motion and episodes of knee joint effusions. There were no joint deformities, no scoliosis, and no cardiac symptoms. He had had spherophakia and lens dislocation since childhood
  1245. >One or several episodes of knee joint effusion with moderate pain had occurred in 5 individuals. These episodes may have been related to moderate physical activity. Physical examination did not reveal ongoing joint effusion or other signs of synovitis in any of the family members
  1246. >Stahl-Hallengren et al. (1994) identified a C-to-T transition at nucleotide 364. This mutation substituted a cysteine for arginine-122 (R122C
  1247. >Stevenson et al. (1982) gave the clinical description of 2 families with ectopia lentis in association with dolichostenomelia and joint stiffness
  1248.  
  1249. 002: 4q; FGF5 (-/-) Position: 80266984
  1250. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=587777579
  1251. \https://www.omim.org/entry/165190#0001
  1252. >1-BP DEL [...] Whole-mount immunofluorescence studies of plucked forearm hair fibers demonstrated complete absence of FGF5 and very low levels of FGF5S in patient hair compared to controls
  1253. \https://en.wikipedia.org/wiki/FGF5
  1254. >In numerous genetic studies of long haired phenotypes of animals it has been shown that small changes in the FGF5 gene can disrupt its expression, leading to an increase in the length of the anagen phase of the hair cycle, resulting in phenotypes with extremely long hair
  1255. >This has been demonstrated in many species, including cats [9],,[10] dogs [11], [12] mice,[8] rabbits,[13] donkeys,[14] sheep and goats,[15] where it is often referred to as the angora mutation
  1256. >Blocking FGF5 in the human scalp extends the hair cycle, resulting in less hair fall, faster hair growth rate and increased hair growth
  1257. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115575/
  1258. >Here, we present, to our knowledge, the first human counterpart of the angora phenotype, showing that FGF5 underlies trichomegaly and is a crucial regulator of hair growth in humans.
  1259.  
  1260. 002b: 4q; FGF5 (--/--) Position: 80266984
  1261. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=587777580
  1262. \https://www.omim.org/entry/165190#0002
  1263. >In affected members of a large consanguineous Pakistani family with trichomegaly (TCMGLY; 190330), Higgins et al. (2014) identified homozygosity for a 2-bp deletion (c.159_160delTA
  1264. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115575/
  1265. >Here, we present, to our knowledge, the first human counterpart of the angora phenotype, showing that FGF5 underlies trichomegaly and is a crucial regulator of hair growth in humans.
  1266.  
  1267. 002c: 4q; FGF5 (-/-) Position: 80286385
  1268. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=587777581
  1269. >Allele T Y[TYR] -> Allele G D[Asp]
  1270. \https://www.omim.org/entry/165190#0003
  1271. >In a Pakistani patient with trichomegaly (TCMGLY; 190330), Higgins et al. (2014) identified homozygosity for a c.520T-C transition in exon 3 of the FGF5 gene, resulting in a tyr174-to-his (Y174H) substitution
  1272. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115575/
  1273. >Here, we present, to our knowledge, the first human counterpart of the angora phenotype, showing that FGF5 underlies trichomegaly and is a crucial regulator of hair growth in humans.
  1274.  
  1275. 003: 6q; FOXO3 (GG;) Position: 108587315
  1276. \https://www.snpedia.com/index.php/Rs2802292
  1277. \https://www.ncbi.nlm.nih.gov/m/pubmed/18765803/
  1278. >Long-lived men also exhibited several biological markers indicative of greater insulin sensitivity and this was associated with homozygosity for the FOXO3A GG genotype
  1279.  
  1280. 003b: 6q; FOXO3 (TT;) Position: 108613258
  1281. \https://www.snpedia.com/index.php/Rs2764264
  1282. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992870/bin/NIHMS250473-supplement-Table_1.doc
  1283. \Oldest Old = CC(8.77,) CT(41.28,) TT(49.95)
  1284.  
  1285. 003c: 6q; FOXO3 (GG;) Position: 108659993
  1286. \https://www.snpedia.com/index.php/Rs12212067
  1287. \https://www.ncbi.nlm.nih.gov/m/pubmed/24035192/
  1288. >We identify a noncoding polymorphism in FOXO3A (rs12212067: T > G) at which the minor (G) allele, despite not being associated with disease susceptibility, is associated with a milder course of Crohn's disease and rheumatoid arthritis and with increased risk of severe malaria
  1289.  
  1290. 003d: 6q; FOXO3 (TT;) Position: 108678084
  1291. \https://www.snpedia.com/index.php/Rs1935949
  1292. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652804/table/T4/?report=objectonly
  1293. \AJC(Ashkenazi Jewish Centenarians) = OR(Odds ratio) CC(-,) CT(1.3,) TT(2.08)
  1294.  
  1295. 004: 2q; FSHR (AA;) Position: 48962782
  1296. \https://www.snpedia.com/index.php/Rs6166
  1297. \https://www.ncbi.nlm.nih.gov/m/pubmed/20335500/
  1298. >AA rs6166 women showed a lower BMD (femoral neck and total body), lower stiffness index (calcaneal QUS), and higher serum levels of bone turnover markers compared to GG rs6166 women. The prevalence of osteoporosis was significantly higher in AA rs6166 women compared with GG rs6166 women
  1299. \https://www.ncbi.nlm.nih.gov/m/pubmed/16630814/
  1300. >Bone mass is increased and osteoclastic resorption is decreased in haploinsufficient FSHbeta+/- mice with normal ovarian function, suggesting that the skeletal action of FSH is estrogen independent
  1301. >We suggest that high circulating FSH causes hypogonadal bone loss
  1302. \https://en.wikipedia.org/wiki/Follicle-stimulating_hormone
  1303. >When the follicle matures and reaches 8–10 mm in diameter it starts to secrete significant amounts of estradiol [...] The sharp increase in estradiol production [...] cause a positive effect on the hypothalamus and pituitary and rapid GnRH pulses occur and an LH surge results. [...] The increase in serum estradiol levels cause a decrease in FSH production by inhibiting GnRH production
  1304. \https://en.wikipedia.org/wiki/Estradiol#Skeletal_system
  1305. >Estradiol has a profound effect on bone. Individuals without it (or other estrogens) will become tall and eunuchoid, as epiphyseal closure is delayed or may not take place. Bone structure is affected also, resulting in early osteopenia and osteoporosis.[21] Also, women past menopause experience an accelerated loss of bone mass due to a relative estrogen deficiency.[22]
  1306. \https://en.wikipedia.org/wiki/Aromatase_excess_syndrome
  1307. >FSH levels are said to be consistently low in the condition, while LH levels are in the low to normal range
  1308. \https://en.wikipedia.org/wiki/Follicle-stimulating_hormone_receptor
  1309. >Estrogen upregulates FSH receptor sites
  1310. \FSH+ = Estradiol+ = GnRH-/BMD+/FSHR+ = FSH- (rs6166-G)
  1311. \FSH- = Estradiol- = GnRH+/BMD-/FSHR- = FSH+ (rs6166-A)
  1312.  
  1313. 004b: 2q; FSHR (TT;) Position: 48974189
  1314. \https://www.snpedia.com/index.php/Rs2268363
  1315. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2268363
  1316. \MAF = G
  1317. \https://www.ncbi.nlm.nih.gov/m/pubmed/20932654/
  1318. >SNPs) Associated with the Development of Erectile Dysfunction in African-American Men Following Radiotherapy for Prostate Cancer
  1319. >rs2268363, MAF frequency = Cases(6.11,) Controls(0.183)
  1320. >MAF frequency = CEU(0.1,) YRI(0.592)
  1321. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628192/table/T2/?report=objectonly
  1322. >FSH = Decreased (Libido)(7.6,) Normal (Libido)(8.9)
  1323. >Therefore T = FSH+, G = FSH-
  1324.  
  1325. 005: 16q; FTO (AA;) Position: 53809247
  1326. \http://www.pdgene.org/view?poly=rs1121980
  1327. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1328. >rs1121980, Waist size(cm)/Trunk total fat %/Leg total fat % = GG(92.6|53.2/33.6,) GA(98.0|53.3/34.1,) AA(94.0|50.6/35.9)
  1329.  
  1330. 005b: 16q; FTO (CC;) Position: 53800954
  1331. \http://www.pdgene.org/view?poly=rs1421085
  1332. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1333. >rs1421085, Waist size(cm)/Trunk total fat %/Leg total fat % = TT(90.4|52.9/34.0,) TC(98.7|53.3/34.0,) CC(95.4|49.7/36.4)
  1334.  
  1335. 005c: 16q; FTO (AA;) Position: 53803574
  1336. \http://www.pdgene.org/view?poly=rs1558902
  1337. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1338. >rs1558902, Waist size(cm)/Trunk total fat %/Leg total fat % = TT(91.4|53.2/33.8,) TA(98.9|53.4/33.9,) AA(95.7|49.8/36.3)
  1339.  
  1340. 005d: 16q; FTO (TT;) Position: 53818460
  1341. \http://www.pdgene.org/view?poly=rs3751812
  1342. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1343. >rs3751812, Waist size(cm)/Trunk total fat %/Leg total fat % = GG(92.3|53.4/33.5,) GT(97.7|53.4/33.9,) TT(97.7|48.8/37.9)
  1344.  
  1345. 005e: 16q; FTO (GG;) Position: 53830465
  1346. \http://www.pdgene.org/view?poly=rs9930506
  1347. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1348. >rs9930506, Waist size(cm)/Trunk total fat %/Leg total fat % = AA(92.4|53.0/33.7,) AG(97.3|53.3/34.0,) GG(97.8|50.9/35.9)
  1349.  
  1350. 005f: 16q; FTO (AA;) Position: 53820527
  1351. \http://www.pdgene.org/view?poly=rs9939609
  1352. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1353. >rs9930609, Waist size(cm)/Trunk total fat %/Leg total fat % = TT(92.3|53.5/33.5,) TA(97.4|53.1/34.2,) AA(100.0|50.0/36.6)
  1354.  
  1355. 005g: 16q; FTO (TT;) Position: 53825488
  1356. \http://www.pdgene.org/view?poly=rs9941349
  1357. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1358. >rs9941349, Waist size(cm)/Trunk total fat %/Leg total fat % = CC(92.5|53.2/33.6,) CT(97.3|53.2/34.1,) TT(97.7|50.9/35.9)
  1359.  
  1360. G
  1361.  
  1362. 001: 2q; GAD1 (GG;) Position: 170816965
  1363. \https://www.snpedia.com/index.php/Rs3749034
  1364. \http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758549/?report=classic
  1365. >As predicted, patients with the risk-associated G/G genotype at rs3749034 had a significant decrease in KCC2 mRNA expression in the hippocampus
  1366. >In the hippocampus of patients with schizophrenia, GAD25/GAD67 and NKCC1/KCC2 ratios are increased and KCC2 levels are decreased, reflecting a potentially immature state of the GABA system
  1367. >Remarkably, these increased GAD25/GAD67 and NKCC1/KCC2 expression ratios in hippocampus are associated with the GAD1 genotype, with risk alleles predicting the relatively less mature pattern
  1368.  
  1369. 001b: 2q; GAD1 (AA;) Position: 170852920
  1370. \https://www.snpedia.com/index.php/Rs769391
  1371. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594692/#!po=6.00000
  1372. >low CSF GABA concentrations are observed in a variety of epileptic syndromes, including genetic models of epilepsy
  1373. >Figure 2b shows that 14.6% of subjects with the AA genotype had PTS activity, while 3.7% of those with the AG genotype and 6.25% of those with the GG genotype had PTS activity
  1374.  
  1375. 002: 10q; GAD2 (GG;) Position: 26216567
  1376. \https://www.snpedia.com/index.php/Rs2236418
  1377. \https://www.ncbi.nlm.nih.gov/m/pubmed/25966064/
  1378. >The frequency distributions of the AA, AG, and GG genotypes in the polymorphic site rs2236418 in the diabetes GAD-Ab-positive group were 45.9, 42.8, and 11.4%, respectively, whereas those in the control group were 36.6, 43.7, and 19.8%
  1379.  
  1380. 002b: 10q; GAD2 (AA;) Position: 26216756
  1381. \https://www.snpedia.com/index.php/Rs185649317
  1382. \https://www.geneticsmr.com/articles/relationship-between-serum-gadab-and-the-genetic-polymorphisms-of-gad2-and-type-2-diabetes-mellitus.pdf
  1383. >The frequency distributions of AA, AG, and GG in theT2-DM group were 6.6, 39.4, and 53.9%, respectively. The frequency distributions of AA, AG, and GG in the healthy control group were 6.0, 40.6, and 53.4%
  1384.  
  1385. 002c: 10q; GAD2 (TT;) Position: 26216765
  1386. \https://www.snpedia.com/index.php/Rs8190590
  1387. \https://www.geneticsmr.com/articles/relationship-between-serum-gadab-and-the-genetic-polymorphisms-of-gad2-and-type-2-diabetes-mellitus.pdf
  1388. >The frequency distributions of CC, CT, and TT in the T2-DM group were 52.1, 36.4, and 11.5%, respectively. The frequency distributions of CC, CT, and TT in the control group were 44.4, 39.4, and 16.2%
  1389.  
  1390. 003: 10q; GATA3 (GG;) Position: 8272081
  1391. \https://www.snpedia.com/index.php/Rs17143387
  1392. \https://www.ncbi.nlm.nih.gov/snp/rs17143387#frequency_tab
  1393. >African (T=0.946, G=0.054,) East Asian (T=0.532, G=0.468)
  1394. \http://www.nature.com/articles/ncomms10815/tables/1
  1395. >Hair shape [...] GATA3 [...] Alleles ancestral>derived: T>G
  1396.  
  1397. 004: 17q; GH1 (AA;) Position: 61995030
  1398. \http://www.pdgene.org/view?poly=rs2665802
  1399. \https://www.ncbi.nlm.nih.gov/m/pubmed/20650818/
  1400. >+1169A allele of the A/T single nucleotide polymorphism (SNP; rs2665802
  1401. >the +1169A allele contributes directly to the observed reduction in both GH1 gene expression and GH secretion
  1402.  
  1403. 004b: 17q; GH1 (AA;) Position: 63918016
  1404. \https://www.snpedia.com/index.php/Rs71640277
  1405. \https://www.omim.org/entry/139250#0009
  1406. >Cogan et al. (1995) reported a G-to-A transition of the first base of the donor splice site of intron 3 (IVS3+1G-A) in the GH1 gene in subjects with isolated growth hormone deficiency type II
  1407.  
  1408. 004c: 17q; GH1 (AA;) Position: 63917337
  1409. \https://www.snpedia.com/index.php/Rs137853223
  1410. \https://www.omim.org/entry/139250#23
  1411. >In a large kindred with dominant growth hormone deficiency (IGHD2; 173100) Gertner et al. (1998) detected a heterozygous G-to-A transition at nucleotide 6664 in exon 5 of the GH1 gene, resulting in an arg183-to-his substitution (R183H
  1412. >Hess et al. (2007) studied the phenotype-genotype correlation of subjects with IGHD2 caused by an R183H mutation
  1413. >The affected subjects in family 1 were significantly shorter (-2.6 vs -0.1 standard deviation score (SDS), p less than 0.0001) and had significantly lower IGF1 (147440) serum levels (-1.9 vs -0.5 SDS, p less than 0.0001), compared with family members with a normal genotype
  1414. >The affected adults exhibited great variability in their stature, ranging from -4.5 to -1.0 SD (mean -2.8 SDS), with 5 members being of normal height (greater than -2 SDS
  1415.  
  1416. 005: Xq; GPR143 (CC;) Position: 9759390
  1417. \https://www.snpedia.com/index.php/Rs137852296
  1418. \https://www.omim.org/entry/300808#3
  1419. >In a patient with OA1 (300500), Schnur et al. (1998) identified a missense mutation that converted codon 133 from TGG (trp) to CGG (arg) (W133R). The patients also showed developmental delay and renal and immune dysfunction. In another family, the same W133R mutation was found. That family was of interest because a manifesting female had a 45,XO karyotype (Turner syndrome
  1420.  
  1421. 005b: Xq; GPR143 (AA;) Position: 9743637
  1422. \https://www.snpedia.com/index.php/Rs137852297
  1423. \https://www.omim.org/entry/300808#5
  1424. >a patient with OA1 (300500) characterized by the presence of giant pigment granules in melanocytes, Schnur et al. (1998) identified a thr232-to-lys (T232K) missense mutation resulting from a change of ACG to AAG in the OA1 gene. The mother had a normal fundus examination; the mother and the affected grandfather had 'vitiligo
  1425.  
  1426. 005c: Xq; GPR143 (TT;) Position: 9760811
  1427. \https://www.snpedia.com/index.php/Rs137852298
  1428. \https://www.omim.org/entry/300808#9
  1429. >NYSTAGMUS, 6, CONGENITAL, X-LINKED
  1430. >In a large 6-generation Chinese family in which 8 males had congenital nystagmus (NYS6; 300814), Liu et al. (2007) identified a 266C-T transition in exon 2 of the GPR143 gene, resulting in a ser89-to-phe (S89F) substitution
  1431.  
  1432. 005d: Xq; GPR143 (AA;) Position: 9759332
  1433. \https://www.snpedia.com/index.php/Rs58933950
  1434. \https://www.omim.org/entry/300808#4
  1435. >In a patient with ocular albinism (OA1; 300500) and giant pigment granules in melanocytes, Schnur et al. (1998) demonstrated a mutation changing codon 152 from AGC (ser) to AAC (asn) (S152N) in the OA1 gene
  1436.  
  1437. 005e: Xq; GPR143 (AA;) Position: 9765714
  1438. \https://www.snpedia.com/index.php/Rs62635018
  1439. \https://www.omim.org/entry/300808#8
  1440. >In a study of 9 families with X-linked ocular albinism (OA1; 300500), Rosenberg and Schwartz (1998) identified 7 pathogenic mutations. Only 1 of these, gly35 to asp (G35D
  1441. >https://www.nature.com/articles/5200226.pdf
  1442. >In all patients an aberrant SSCA pattern was found. Direct sequencing revealed the mutations 164G>A (G35D)
  1443.  
  1444. 006: 2q; GRB14 (CC;) Position: 165513091
  1445. \Citations: http://www.pdgene.org/view?poly=rs10195252
  1446. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  1447. >aEffect Allele: WHR increasing allele on the forward strand;
  1448. >GBR14, EA = T
  1449.  
  1450. 007: 10q; GRID1 (TT;) Position: 86233584
  1451. \https://www.snpedia.com/index.php/Rs2814331
  1452. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2814331
  1453. \http://www.nature.com/articles/ncomms10815/tables/1
  1454.  
  1455. H
  1456.  
  1457. 001: 15q; HERC2 (GG;) Position: 28111713
  1458. \https://www.snpedia.com/index.php/Rs1129038
  1459. \https://www.ncbi.nlm.nih.gov/pubmed/18172690?dopt=Abstract
  1460.  
  1461. 001b: 15q; HERC2 (CC;) Position: 28120472
  1462. \https://www.snpedia.com/index.php/Rs12913832
  1463. \https://www.nature.com/articles/jhg201138
  1464. >carriers possessing CC, CA or AA genotypes in rs12896399 with CC genotype in rs12913832 are all classified into the group of ‘high-risk’ of having blue eye colour [...] Detailed analysis indicates that the chances of having blue eye colour rise with A allele in rs12896399 [...] and the highest chances of having blue eye colour are with AA genotype in rs12896399, but only on condition of possessing CC genotype in rs12913832. The allele T in rs12913832 in HERC2 masks this effect and, independently of the genotype in rs12896399, individuals possessing the T allele in rs12913832 are classified into the group of ‘low-risk’ of having blue eye colour
  1465.  
  1466. 001c: 15q; HERC2 (GG;) Position: 28285036
  1467. \https://www.snpedia.com/index.php/Rs1667394
  1468. \https://www.ncbi.nlm.nih.gov/m/pubmed/17952075/
  1469. >Blue versus brown eyes = rs1667394-A = Discovery OR(29.43,) Replication OR(18.46,) Netherlands OR(15.34) [...] Blue versus green eyes = Discovery OR(6.74,) Replication OR(5.83,) Netherlands OR(5.96) [...] Red versus non-red hair = rs1667394-A = Discovery OR(0.91,) Replication OR(0.81,) Netherlands OR(1.44) [...] Blond versus brown hair = rs1667394-A = Discovery OR(4.94,) Replication OR(5.96,) Netherlands OR(5.51)
  1470.  
  1471. 001d: 15q; HERC2 (CC;) Position: 28208069
  1472. \https://www.snpedia.com/index.php/Rs2238289
  1473. \https://www.ncbi.nlm.nih.gov/m/pubmed/18172690/
  1474.  
  1475. 001e: 15q; HERC2 (TT;) Position: 28182840
  1476. \https://www.snpedia.com/index.php/Rs7170852
  1477. \https://www.ncbi.nlm.nih.gov/m/pubmed/18172690/
  1478.  
  1479. 001f: 15q; HERC2 (AA;) Position: 28120587
  1480. \https://www.snpedia.com/index.php/Rs7183877
  1481. \https://www.ncbi.nlm.nih.gov/pubmed/18172690?dopt=Abstract
  1482.  
  1483. 001g: 15q; HERC2 (CC;) Position: 28243742
  1484. \https://www.snpedia.com/index.php/Rs8028689
  1485. \https://www.ncbi.nlm.nih.gov/pubmed/18172690?dopt=Abstract
  1486.  
  1487. 001h: 15q; HERC2 (AA;) Position: 28268218
  1488. \https://www.snpedia.com/index.php/Rs916977
  1489. \https://www.ncbi.nlm.nih.gov/pubmed/18172690?dopt=Abstract
  1490.  
  1491. 001i: 15q; HERC2 (GG;) Position: 27985172
  1492. \https://www.snpedia.com/index.php/Rs1800407
  1493. \https://www.nature.com/articles/jhg201138
  1494. >Green versus non-green eye colour is, according to MDR, best predicted by a three-factor model consisting of rs12913832 in HERC2, rs1408799 in TYRP1 and rs1800407 in OCA2 [...] The rs12913832 position removes 0.28% of ‘uncertainty’ in green eye colour prediction, rs1408799 removes 0.23% and the interaction between them eliminates an additional 1.23%
  1495. \https://www.nature.com/articles/jhg201138/figures/2
  1496. >rs1800407, Green/non-Green eyes, AA=0/2, AG=18/58, GG=15/210
  1497.  
  1498. 002: 6q; HLA-DQA1 (AA;) Position: 32638107
  1499. \https://www.snpedia.com/index.php/Rs2187668
  1500. \https://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-016-0211-8#Tab2
  1501.  
  1502. 003: 6q; HMGA1 (CC;) Position: 34246545
  1503. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1150781
  1504. >Ancestral Allele = G [...] G(G, Gly) -> C(A, Ala) [...] Frequency = CEU(CC=0.862, CG=0.137, GG=0.000,) HCB(CC=0.822, CG=0.155, GG=0.022,) YRI(CC=0.305, CG=0.491, GG=0.203)
  1505. \https://www.sciencedirect.com/science/article/pii/S000292971000594X#!
  1506. >Table 1. Sixty-Four Loci Showing Significant Evidence for Association with Adult Height [...] rs1150781, Effect Allele = C, Effect(0.73)
  1507.  
  1508. 004: 12q; HMGA2 (TT;) Position: 65964567
  1509. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1042725
  1510. >Ancestral Allele = C [...] Frequency = CEU(CC=0.283, CT=0.424, TT=0.292,) HCB(CC=0.023, CT=0.441, TT=0.534,) YRI(CC=0.401, CT=0.508, TT=0.089)
  1511. \https://www.snpedia.com/index.php/Rs1042725
  1512. \http://www.nature.com/ng/journal/v39/n10/abs/ng2121.html
  1513. >We estimate that rs1042725 explains ∼0.3% of population variation in height (∼0.4 cm increased adult height per C allele)
  1514. >Note: HMGA2 is much more generally expressed throughout the body than HMGA1, and if the ancestral allele is associated with greater height it's probably also associated with a general archaic appearance. As well, rs1150781-C of HMGA1 is derived while being associated with greater stature, while rs1042725-C is ancestral while being associated with greater height.
  1515.  
  1516. 004b: 12q; HMGA2 (CC;) Position: 65950030
  1517. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10784502
  1518. >Ancestral Allele = T [...] Frequency = CEU(CC=0.265, CT=0.415, TT=0.318,) HCB(CC=0.000, CT=0.232, TT=0.767,) YRI(CC=0.327, CT=0.495, TT=0.176)
  1519. \https://www.snpedia.com/index.php/Rs10784502
  1520. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635491/
  1521. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635491/bin/NIHMS378125-supplement-supp_tables.docx
  1522. >rs10784502, Effect Allele = T, non-Effect Allele = C, Effect(-11860.7)
  1523.  
  1524. 004c: 12q; HMGA2 (TT;) Position: 65961131
  1525. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=867633
  1526. >Ancestral Allele = C [...] Fwd = C/T, Rev = A/G, T-A/G-T, so A=C, G=T [...] Frequency = CEU(CC=0.416, CT=0.383, TT=0.200,) HCB(CC=0.022, CT=0.355, TT=0.622,) YRI(CC=0.533, CT=0.383, TT=0.083)
  1527. \https://www.sciencedirect.com/science/article/pii/S000292971000594X#!
  1528. >Table 1. Sixty-Four Loci Showing Significant Evidence for Association with Adult Height [...] rs867633, Effect Allele = A, Effect(-0.39)
  1529.  
  1530. 005: 12q; HOXC10 (AA;) Position: 54384387
  1531. \Citations: http://www.pdgene.org/view?poly=rs7302703
  1532. \https://academic.oup.com/hmg/article/23/9/2498/632550/Gene-centric-meta-analyses-for-central-adiposity
  1533. \was associated with increased WHR [...] as was rs7302703-G in HOXC10
  1534.  
  1535. 006: 12q; HOXC13 (CC;) Position: 54342684
  1536. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1443512
  1537. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  1538. >aEffect Allele: WHR increasing allele on the forward strand;
  1539. >HOXC13, EA = A
  1540.  
  1541. 007: 2q; HOXD3 (AA;) Position: 176139387
  1542. \https://www.snpedia.com/index.php/Rs4078756
  1543. \https://www.ncbi.nlm.nih.gov/m/pubmed/28691018/
  1544.  
  1545. 007b: 2q; HOXD3 (TT;) Position: 176151087
  1546. \https://www.snpedia.com/index.php/Rs13418078
  1547. \https://www.ncbi.nlm.nih.gov/m/pubmed/20686522/
  1548.  
  1549. 007c: 2q; HOXD3 (AA;) Position: 176150242
  1550. \https://www.snpedia.com/index.php/Rs1867863
  1551. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028147/#!po=38.8889
  1552.  
  1553. 008: 2q; HOXD10 (AA;) Position: 176119164
  1554. \https://www.snpedia.com/index.php/Rs104893634
  1555. \https://www.ncbi.nlm.nih.gov/clinvar/variation/14878/
  1556.  
  1557. 009: 17q; HSD17B1 (AA;) Position: 42552898
  1558. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=201739205
  1559. \https://www.ncbi.nlm.nih.gov/m/pubmed/26694100/
  1560. >point mutation vIV (A -> C) was located in the putative TATA box of the EDH17B2 gene [...] the mutation vIV decreases EDH17B2 promoter activity by an average of 45%
  1561. \https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/hsd17b1
  1562. >The type 1 enzyme (HSD17B1) is referred to as the “estrogenic” 17β-HSD because it catalyzes the final step in estrogen biosynthesis by preferentially reducing the weak estrogen estrone to yield the potent estrogen 17β-estradiol
  1563.  
  1564. 010: 13q; HTR2A (GG;) Position: 46867572
  1565. \https://www.snpedia.com/index.php/Rs1328674
  1566.  
  1567. 010b; 13q; HTR2A (TT;) Position: 46897343
  1568. \https://www.snpedia.com/index.php/Rs6311
  1569.  
  1570. 010c; 13q; HTR2A (TT;) Position: 46895805
  1571. \https://www.snpedia.com/index.php/Rs6313
  1572. \https://www.ncbi.nlm.nih.gov/m/pubmed/18006541/
  1573.  
  1574. 010d; 13q; HTR2A (TT;) Position: 46834899
  1575. \https://www.snpedia.com/index.php/Rs6314
  1576. \https://www.ncbi.nlm.nih.gov/m/pubmed/18006541/
  1577.  
  1578. 010e; 13q; HTR2A (GG;) Position: 46854476
  1579. \https://www.snpedia.com/index.php/Rs643627
  1580. \https://www.ncbi.nlm.nih.gov/m/pubmed/16814396/
  1581.  
  1582. 010f; 13q; HTR2A (AA;) Position: 46835968
  1583. \https://www.snpedia.com/index.php/Rs7322347
  1584. \http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117792
  1585.  
  1586. 010g; 13q; HTR2A (CC;) Position: 46855311
  1587. \https://www.snpedia.com/index.php/Rs7984966
  1588. \https://www.ncbi.nlm.nih.gov/m/pubmed/27230021/
  1589.  
  1590. 010h; 13q; HTR2A (GG;) Position: 46837850
  1591. \https://www.snpedia.com/index.php/Rs7997012
  1592. \https://www.ncbi.nlm.nih.gov/m/pubmed/16642436/
  1593.  
  1594. 011: 2q; HTR2B (CC;) Position: 231115305
  1595. \https://www.snpedia.com/index.php/Rs10194776
  1596. \https://www.ncbi.nlm.nih.gov/m/pubmed/19455600/
  1597.  
  1598. 011b: 2q; HTR2B (AA;) Position: 231116063
  1599. \https://www.snpedia.com/index.php/Rs16827801
  1600. \https://www.ncbi.nlm.nih.gov/m/pubmed/19455600/
  1601.  
  1602. 011c: 2q; HTR2B (TT;) Position: 231123707
  1603. \https://www.snpedia.com/index.php/Rs79874540
  1604. \https://www.ncbi.nlm.nih.gov/m/pubmed/21179162/
  1605.  
  1606. 012: Xq; HTR2C (GG;) Position: 114903581
  1607. \https://www.snpedia.com/index.php/Rs1414334
  1608. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558473/
  1609.  
  1610. 012b: Xq; HTR2C (GG;) Position: 114765807
  1611. \https://www.snpedia.com/index.php/Rs2428707
  1612. \https://www.ncbi.nlm.nih.gov/m/pubmed/28260903/
  1613.  
  1614. 012c: Xq; HTR2C (TT;) Position: 114584047
  1615. \https://www.snpedia.com/index.php/Rs3813929
  1616. \https://www.ncbi.nlm.nih.gov/m/pubmed/19434072/
  1617.  
  1618. 012d: Xq; HTR2C (TT;) Position: 114849062
  1619. \https://www.snpedia.com/index.php/Rs4272555
  1620. \https://www.ncbi.nlm.nih.gov/m/pubmed/28260903/
  1621.  
  1622. 012e: Xq; HTR2C (TT;) Position: 114590222
  1623. \https://www.snpedia.com/index.php/Rs498177
  1624. \https://www.ncbi.nlm.nih.gov/m/pubmed/21185157/
  1625.  
  1626. 012f: Xq; HTR2C (CC;) Position: 114584109
  1627. \https://www.snpedia.com/index.php/Rs518147
  1628. \https://www.ncbi.nlm.nih.gov/m/pubmed/19434072/
  1629.  
  1630. 012g: Xq; HTR2C (AA;) Position: 114583441
  1631. \https://www.snpedia.com/index.php/Rs521018
  1632. \https://www.ncbi.nlm.nih.gov/m/pubmed/21185157/
  1633.  
  1634. I
  1635.  
  1636. 001: 15q; IGFR1 (AA;) Position: 98908747
  1637. \https://www.snpedia.com/index.php/Rs34516635
  1638. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265137/
  1639. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265137/table/T2/?report=objectonly
  1640. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=34516635
  1641.  
  1642. 001b: 15q; IGFR1 (AA;) Position: 98693273
  1643. \https://www.snpedia.com/index.php/Rs1976667
  1644. \https://www.ncbi.nlm.nih.gov/m/pubmed/22172258/
  1645.  
  1646. 001c: 15q; IGFR1 (AA;) Position: 98934996
  1647. \https://www.snpedia.com/index.php/Rs2229765
  1648. \https://www.ncbi.nlm.nih.gov/m/pubmed/19460140/
  1649.  
  1650. 002: Xq; IL3RA (CC;) Position: 1352044
  1651. \https://www.snpedia.com/index.php/Rs6422441
  1652. \http://www.nature.com/mp/journal/v12/n6/fig_tab/4001983t2.html#figure-title
  1653.  
  1654. 002b: Xq; IL3RA (GG;) Position: 1352245
  1655. \https://www.snpedia.com/index.php/Rs6603272
  1656. \http://www.nature.com/mp/journal/v12/n6/fig_tab/4001983t2.html#figure-title
  1657.  
  1658. 002c: Xq; IL3RA (CC;) Position: 1352649
  1659. \https://www.snpedia.com/index.php/Rs17883192
  1660. \http://www.nature.com/mp/journal/v12/n6/fig_tab/4001983t2.html#figure-title
  1661.  
  1662. 003: 7q; IL6 (GG;) Position: 22727026
  1663. \https://www.snpedia.com/index.php/Rs1800795
  1664. \https://www.ncbi.nlm.nih.gov/m/pubmed/15664628/
  1665. \https://www.ncbi.nlm.nih.gov/m/pubmed/22695063/
  1666.  
  1667. 003b: 7q; IL6 (TT;) Position: 22727518
  1668. \https://www.snpedia.com/index.php/Rs2069830
  1669. \https://www.ncbi.nlm.nih.gov/m/pubmed/18727828/
  1670.  
  1671. 004: Xq; IRAK1 (TT;) Position: 154018741
  1672. \https://www.snpedia.com/index.php/Rs1059702
  1673. \https://www.ncbi.nlm.nih.gov/m/pubmed/21933552/
  1674. \https://www.ncbi.nlm.nih.gov/m/pubmed/21898345/
  1675. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848422/
  1676.  
  1677. 004b: Xq; IRAK1 (TT;) Position: 154013378
  1678. \https://www.snpedia.com/index.php/Rs1059703
  1679. \https://www.ncbi.nlm.nih.gov/m/pubmed/23233309/
  1680.  
  1681. 004c: Xq; IRAK1 (AA;) Position: 154010439
  1682. \https://www.snpedia.com/index.php/Rs3027898
  1683. \https://www.ncbi.nlm.nih.gov/m/pubmed/20500689/
  1684.  
  1685. 004: 6q; IRF4 (TT;) Position: 396321
  1686. \https://www.snpedia.com/index.php/Rs12203592
  1687. \http://www.nature.com/articles/ncomms10815/tables/1
  1688.  
  1689. 005: 16q; ITGAL (CC;) Position: 30481502
  1690. \https://www.snpedia.com/index.php/Rs1064524
  1691. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043868/
  1692.  
  1693. 006: 12q; ITPR2 (AA;) Position: 26344550
  1694. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=718314
  1695. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  1696. >aEffect Allele: WHR increasing allele on the forward strand;
  1697. >ITPR2, EA = G
  1698.  
  1699. J
  1700. K
  1701.  
  1702. 001: 12q; KITLG (TT;) Position: 88934558
  1703. \https://www.snpedia.com/index.php/Rs12821256
  1704. \https://www.ncbi.nlm.nih.gov/m/pubmed/17952075/
  1705. >Blue versus brown eyes = rs12821256-C = Discovery OR(1.13,) Replication OR(1.20,) Netherlands OR(0.96) [...] Blue versus green eyes = rs12821256-C = Discovery OR(0.92,) Replication OR(1.09,) Netherlands OR(1.18) [...] Red versus non-red hair = rs12821256-C = Discovery OR(1.01,) Replication OR(0.88,) Netherlands OR(0.65) [...] Blond versus brown hair = rs12821256-C = Discovery OR(2.32,) Replication OR(1.90,) Netherlands OR(2.43)
  1706.  
  1707. 001b: 12q; KITLG (GG;) Position: 88905969
  1708. \https://www.snpedia.com/index.php/Rs642742
  1709. \https://omim.org/entry/184745#0002
  1710. >The frequency of the ancestral A allele is at least 92% in West Africans, whereas the frequency of the derived G allele is at least 86% in Europeans and East Asians. Admixture mapping suggested that replacement of 2 West African alleles (AA) with 2 European alleles (GG) may account for a lightening of a person's skin by 6 to 7 melanin units. In comparison, the overall skin reflectance difference between West Africans and Europeans is 30 melanin units
  1711.  
  1712. 001c: 12q; KITLG (CC;) Position: 88559549
  1713. \https://www.snpedia.com/index.php/Rs3782179
  1714. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865677/
  1715. >testicular germ cell tumors (TGCT [...] TGCT risk was increased three-fold per copy of the major A-allele in KITLG rs3782179
  1716. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3782179
  1717.  
  1718. 001d: 12q; KITLG (GG;) Position: 88560182
  1719. \https://www.snpedia.com/index.php/Rs4474514
  1720. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865677/
  1721. >testicular germ cell tumors (TGCT [...] TGCT risk was increased three-fold per copy of the major A-allele in KITLG [...] and rs4474514
  1722.  
  1723. 001e: 12q; KITLG (AA;) Position: 88559882
  1724. \https://www.snpedia.com/index.php/Rs4590952
  1725. \http://www.cell.com/cell/fulltext/S0092-8674(13)01154-9
  1726. >rs4590952, G/A [...] However, the PWM score decreases dramatically with the A allele
  1727.  
  1728. 002: 3q; KPNA4 (CC;) Position: 160508519
  1729. \https://www.snpedia.com/index.php/Rs17236529
  1730. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043868/
  1731.  
  1732. L
  1733.  
  1734. 001: 1q; LEPR (GG;) Position: 66058513
  1735. \http://www.pdgene.org/view?poly=rs1137101
  1736. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1737.  
  1738. 002: 11q; LRP5 (GG;) Position: 68192346
  1739. \Citations: http://www.pdgene.org/view?poly=rs599083
  1740. \>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321886/?report=classic
  1741. \>These revealed that adipocyte numbers in android fat tended to be lower in carriers of the low BMD-associated allele at rs599083 (GG, GT) versus homozygous carriers of the common allele (TT) (p = 0.05
  1742.  
  1743. 003: 6q; LY86 (AA;) Position: 6688148
  1744. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1294421
  1745. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  1746. >aEffect Allele: WHR increasing allele on the forward strand;
  1747. >LY86, EA = G
  1748.  
  1749. 004: 1q; LYPLAL1 (TT;) Position: 217817340
  1750. \Citations: https://www.genome.gov/pages/research/dir/waisthipratio.pdf
  1751. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926774/
  1752. \TT-allele carriers showed furthermore lower scores for Hunger (74%, p < 0.001), lower Disinhibition (53%, p < 0.001), and higher Cognitive restraint (21%, p = 0.017) than GG/GT carriers
  1753.  
  1754. 004b: 1q; LYPLAL1 (TT;) Position: 217817340
  1755. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4846567
  1756. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  1757. >aEffect Allele: WHR increasing allele on the forward strand;
  1758. >LYPLAL1, EA = G
  1759.  
  1760. M
  1761.  
  1762. 001: 2q; MAP2 (GG;) Position: 209633537
  1763. \https://www.snpedia.com/index.php/Rs9288410
  1764. \https://www.ncbi.nlm.nih.gov/books/NBK25535/
  1765.  
  1766. 002: 17q; MAP3K3 (TT;) Position: 63647335
  1767. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=8081612
  1768. >Ancestral Allele = T [...] Frequency = CEU(CC=0.522, CT=0.389, TT=0.088,) HCB(CC=0.930, CT=0.069, TT=0.000,) YRI(CC=0.026, CT=0.238, TT=0.734)
  1769. \https://www.sciencedirect.com/science/article/pii/S000292971000594X#!
  1770. >Table 1. Sixty-Four Loci Showing Significant Evidence for Association with Adult Height [...] rs8081612, Effect Allele = T, Effect(0.37)
  1771.  
  1772. 003: 16q; MC1R (AT;) Position: 89919733
  1773. \https://www.snpedia.com/index.php/Rs104894523
  1774. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104894523
  1775.  
  1776. 003b: 16q; MC1R (TT;) Position: 89919728
  1777. \https://www.snpedia.com/index.php/Rs104894524
  1778.  
  1779. 003c: 16q; MC1R (TT;) Position: 89919722
  1780. \https://www.snpedia.com/index.php/Rs1110400
  1781.  
  1782. 003d: 16q; MC1R (AA;) Position: 89919683
  1783. \https://www.snpedia.com/index.php/Rs11547464
  1784.  
  1785. 003e: 16q; MC1R (TT;) Position: 89919436
  1786. \https://www.snpedia.com/index.php/Rs1805005
  1787.  
  1788. 003f: 16q; MC1R (AA;) Position: 89919510
  1789. \https://www.snpedia.com/index.php/Rs1805006
  1790.  
  1791. 003g: 16q; MC1R (TT;) Position: 89919709
  1792. \https://www.snpedia.com/index.php/Rs1805007
  1793. >rs1805007, known as Arg151Cys or R151C
  1794. \https://www.ncbi.nlm.nih.gov/m/pubmed/17952075/
  1795. >Red versus non-red hair = rs1805007-T = Discovery OR(12.47,) Replication OR(6.12,) Netherlands OR(13.02) [...] Blond versus brown hair = rs1805007-T = Discovery OR(2.34,) Replication OR(2.0,) Netherlands OR(1.59)
  1796. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338132/
  1797. >Several studies have been conducted with mixed results since our initial report of increased Parkinson's disease risk in individuals with red hair and/or red hair‐associated p.R151C variant of the MC1R gene
  1798. >We found that red hair (pooled odds ratios = 1.68, 95% confidence intervals: 1.07, 2.64) and p.R151C (pooled odds ratios = 1.10, 95% confidence intervals: 1.00, 1.21), but not p.R160W, were associated with greater risk for Parkinson's disease. Our results support potential roles of pigmentation and its key regulator MC1R in the pathogenesis of Parkinson's disease
  1799.  
  1800. 003h: 16q; MC1R (TT;) Position: 89919736
  1801. \https://www.snpedia.com/index.php/Rs1805008
  1802. \https://www.ncbi.nlm.nih.gov/m/pubmed/17952075/
  1803. >Red versus non-red hair = rs1805008-T = Discovery OR(7.86,) Replication OR(4.53,) Netherlands OR(3.71) [...] Blond versus brown hair = rs1805008-T = Discovery OR(1.88,) Replication OR(1.74,) Netherlands OR(1.93)
  1804.  
  1805. 003i: 16q; MC1R (CC;) Position: 89920138
  1806. \https://www.snpedia.com/index.php/Rs1805009
  1807.  
  1808. 003j: 16q; MC1R (AA;) Position: 89919532
  1809. \https://www.snpedia.com/index.php/Rs2228479
  1810.  
  1811. 003k: 16q; MC1R (AA;) Position: 89919746
  1812. \https://www.snpedia.com/index.php/Rs885479
  1813.  
  1814. 004: 2q; MCM6 (TT;) Position: 135851076
  1815. \https://www.snpedia.com/index.php/Rs4988235
  1816. \http://www.nature.com/ejcn/journal/v71/n1/full/ejcn2016164a.html?foxtrotcallback=true
  1817.  
  1818. 004b: 2q; MCM6 (AA;) Position: 135859184
  1819. \https://www.snpedia.com/index.php/Rs182549
  1820. \http://omim.org/entry/601806
  1821.  
  1822. 004c: 2q; MCM6 (CC;) Position: 135851176
  1823. \https://www.snpedia.com/index.php/Rs145946881
  1824. \http://www.omim.org/entry/601806#0003
  1825.  
  1826. 004d: 2q; MCM6 (GG;) Position: 135851081
  1827. \https://www.snpedia.com/index.php/Rs41380347
  1828. \http://www.omim.org/entry/601806#0004
  1829.  
  1830. 005: 8q; MCPH1 (CC;) Position: 6444662
  1831. \https://www.snpedia.com/index.php/Rs930557
  1832. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=930557
  1833. >Ancestral Allele: G [...] G(D, Asp) -> C(H, His) [...] Frequency = CEU(CC=0.616, CG=0.333, GG=0.050,) HCB(CC=0.644, CG=0.288, GG=0.066,) YRI(CC=0.100, CG=0.483, GG=0.416)
  1834. \https://academic.oup.com/hmg/article/16/6/600/610971
  1835. >To test the hypothesis that the recent selective sweep at ASPM and Microcephalin is due to increased intelligence, we genotyped the diagnostic sites that distinguish the adaptive derived allele (D-allele) from the ancestral allele (A-allele [...] Australian (Largest) sample = MCPH1, AA(FIQ=112.7-/+12.2,) AD(FIQ=113.3-/+12.3,) DD(FIQ=114.2-/+12.7) [...] Genotyping of Microcephalin was performed by automated sequencing of the diagnostic G37995C SNP
  1836. \http://www.sciencedirect.com/science/article/pii/S016028960200137X
  1837. >African-descended people (Blacks) average cranial capacities of 1267 cm3, European-descended people (Whites) 1347 cm3 [...] It must be concluded that the race differences in average brain size are securely established [...] Blacks average an IQ of 85, Whites 100
  1838.  
  1839. 005b: 8q; MCPH1 (AA;) Position: 5917813
  1840. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2816514
  1841. >Ancestral Allele = C [...] Frequency = CEU(AA=0.150, AC=0.349, CC=0.500,) HCB(AA=0.022, AC=0.155, CC=0.822,) YRI(AA=0.000, AC=0.100, CC=0.899)
  1842. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/?report=objectonly
  1843. >rs2816514, Population(Females,) Effect Size([+]44-/+23cm3) [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  1844. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  1845. >rs2816514 = Major/minor = C/A
  1846.  
  1847. 005c: 8q; MCPH1 (AA;) Position: 5920479
  1848. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2816517
  1849. >Ancestral Allele = A [...] Frequency = CEU(AA=0.237, AC=0.406, CC=0.355,) HCB(AA=0.022, AC=0.222, CC=0.755,) YRI(AA=0.000, AC=0.250, CC=0.750)
  1850. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/?report=objectonly
  1851. >rs2816517, Population(Females,) Effect Size([+]37-/+20cm3) [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  1852. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  1853. >rs2816514 = Major/minor = C/A
  1854.  
  1855. 005d: 8q; MCPH1 (CC;) Position: 6208094
  1856. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11779303
  1857. >Ancestral Allele = C [...] CEU(CC=0.026, CG=0.380, GG=0.592,) HCB(CC=0.000, CG=0.116, GG=0.883,) YRI(CC=0.000, CG=0.09, GG=0.909,) MKK(CC=0.076, CG=0.300, GG=0.622)
  1858. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/#!po=16.6667
  1859. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806758/table/t01/?report=objectonly
  1860. >rs11779303, Population(Females,) Effect Size([+]62-/+33cm3) [...] The effect sizes represent increase in volume and area per extra copy of the minor allele
  1861. \http://www.pnas.org/content/pnas/suppl/2009/12/16/0908454107.DCSupplemental/st02.doc
  1862. >rs11779303 = Major/minor = G/C
  1863.  
  1864. 005e: 8q; MCPH1 (CC;) Position: 6621521
  1865. \https://www.snpedia.com/index.php/Rs1057090
  1866. \https://academic.oup.com/hmg/article/17/9/1329/571192
  1867. >SNP2 = rs930557, SNP3 = rs1057090, SNP4 = rs2912016 [...] we observed a significant positive correlation between the CCC haplotype (27.7%) and the cranial volume (P = 0.004) while the CTC haplotype (20.4%) [...] This result indicates that the derived C allele of rs1057090 contributes to the larger cranial volume in the studied males [...] SNP2(C,)SNP3(T,)SNP4(C)=Hap-score(-2.92,) SNP2(C,)SNP3(C,)SNP4(C)=Hap-score(2.93)
  1868.  
  1869. 005f: 8q; MCPH1 (AA;) Position: 6621657
  1870. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2912016
  1871. >Ancestral Allele: A
  1872. \https://academic.oup.com/hmg/article/17/9/1329/571192
  1873. >SNP2 = rs930557, SNP3 = rs1057090, SNP4 = rs2912016 [...] we observed a significant positive correlation between the CCC haplotype (27.7%) and the cranial volume (P = 0.004) while the CTC haplotype (20.4%) [...] This result indicates that the derived C allele of rs1057090 contributes to the larger cranial volume in the studied males [...] SNP2(C,)SNP3(T,)SNP4(C)=Hap-score(-2.92,) SNP2(C,)SNP3(C,)SNP4(C)=Hap-score(2.93)
  1874.  
  1875. 006: Xq; MECP2 (AA;) Position: 154031941
  1876. \https://www.snpedia.com/index.php/Rs2075596
  1877. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1878. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1879.  
  1880. 006b: Xq; MECP2 (CC;) Position: 154033423
  1881. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3027933
  1882. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1883. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1884.  
  1885. 006c: Xq; MECP2 (AA;) Position: 154045127
  1886. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3027939
  1887. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1888. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1889.  
  1890. 006d: Xq; MECP2 (TT;) Position: 154046529
  1891. \https://www.snpedia.com/index.php/Rs17435
  1892. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=17435
  1893. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1894. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1895.  
  1896. 006e: Xq; MECP2 (AA;) Position: 154057430
  1897. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7884370
  1898. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1899. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1900.  
  1901. 006f: Xq; MECP2 (CC;) Position: 154059995
  1902. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1734787
  1903. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1904. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1905.  
  1906. 006g: Xq; MECP2 (AA;) Position: 154065469
  1907. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1734791
  1908. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1909. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1910.  
  1911. 006h: Xq; MECP2 (AA;) Position: 154075609
  1912. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1734792
  1913. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1914. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1915.  
  1916. 006i: Xq; MECP2 (AA;) Position: 154082978
  1917. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2239464
  1918. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/table/T1/?report=objectonly
  1919. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734382/
  1920.  
  1921. 007: 5q; MEGF10 (AA;) Position: 127348117
  1922. \https://www.snpedia.com/index.php/Rs27388
  1923. \https://www.ncbi.nlm.nih.gov/m/pubmed/18179784/
  1924.  
  1925. 008: 20q; MMP24 (GG;) Position: 35231612
  1926. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2425019
  1927. >Ancestral Allele = G [...] Frequency = CEU(AA=0.292, AG=0.548, GG=0.159,) HCB(AA=0.465, AG=0.418, GG=0.116,) YRI(AA=0.000, AG=0.000, GG=1.000)
  1928. \https://www.sciencedirect.com/science/article/pii/S000292971000594X#!
  1929. >Table 1. Sixty-Four Loci Showing Significant Evidence for Association with Adult Height [...] rs2425019, Effect Allele = A, Effect(-0.32)
  1930. >Note: Predominantly expressed in the cerebellum. Yoruba(YRI) Africans are fixed for the G allele, suggesting that rs2425019-G leads to a larger cortex and greater height due to the induction of a long-limbed 'equatorial' phenotype. The archaic (Mesolithic) phenotype of Europe had an average cranial capacity of 1567cc, while modern Europeans average 1362-1391cc;
  1931. \https://www.sciencedirect.com/science/article/pii/S0018442X14000900
  1932. >The most comprehensive records are those from Europe, where Henneberg (1988, 1990) has examined the records of thousands of skulls. He reports a “Mesolithic” mean volume for males of 1567 ml [...] while the males of post-Mediaeval and recent times yielded a mean of 1391 ml
  1933.  
  1934. 009: 8q; MSRA (CC;) Position: 9860080
  1935. \Citations: http://www.pdgene.org/view?poly=rs545854
  1936. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110388/?report=classic
  1937. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  1938.  
  1939. 010: 11q; MTNR1B (CC;) Position: 92975544
  1940. \https://www.snpedia.com/index.php/Rs10830963
  1941. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597741/table/pone-0003962-t003/
  1942.  
  1943. 010b: 11q; MTNR1B (TT;) Position: 92972141
  1944. \https://www.snpedia.com/index.php/Rs12804291
  1945. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597741/table/pone-0003962-t003/
  1946.  
  1947. 010c: 11q; MTNR1B (CC;) Position: 92980341
  1948. \https://www.snpedia.com/index.php/Rs3781638
  1949. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597741/table/pone-0003962-t003/
  1950.  
  1951. 010d: 11q; MTNR1B (CC;) Position: 92968430
  1952. \https://www.snpedia.com/index.php/Rs4753426
  1953. \https://www.ncbi.nlm.nih.gov/m/pubmed/17632395/
  1954.  
  1955. 011: 1q; mTOR (TT;) Position: 11262571
  1956. \https://www.snpedia.com/index.php/Rs2295080
  1957. \https://www.ncbi.nlm.nih.gov/m/pubmed/23209702/
  1958.  
  1959. N
  1960.  
  1961. 001: 16q; NET (TT;) Position: 55692146
  1962. \https://www.snpedia.com/index.php/Rs11568324
  1963. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2587507/
  1964.  
  1965. 001b: 16q; NET (GG;) Position: 55670130
  1966. \https://www.snpedia.com/index.php/Rs187715
  1967. \https://www.ncbi.nlm.nih.gov/m/pubmed/21070505/
  1968.  
  1969. 002: 7q; NFE2L3 (CC;) Position: 25871109
  1970. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1055144
  1971. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  1972. >aEffect Allele: WHR increasing allele on the forward strand;
  1973. >NFE2L3, EA = T
  1974.  
  1975. 003: 4q; NFKB1 (AA;) Position: 102523317
  1976. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1585215
  1977. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720066/
  1978. >Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma
  1979. >rs1585215, Cases(AA=111, AG=250, GG=82,) Controls(AA=151, AG=169, GG=33)
  1980. \https://www.ncbi.nlm.nih.gov/pubmed/26663363
  1981. >The importance of Nfkb1 function can be seen in mouse models, where Nfkb1(-/-) mice display increased inflammation and susceptibility to certain forms of DNA damage, leading to cancer, and a rapid ageing phenotype
  1982.  
  1983. 003b: 4q; NFKB1 (AA;) Position: 102522412
  1984. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1599961
  1985. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720066/
  1986. >Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma
  1987. >rs1599961, Cases(GG=170, GA=221, AA=66,) Controls(GG=128, GA=175, AA=64)
  1988.  
  1989. 003c: 4q; NFKB1 (TT;) Position: 102575280
  1990. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4648022
  1991. >MAF = T
  1992. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735864/
  1993. >SNP rs4648022 is an intronic SNP, with a MAF of 0.06 in cases and 0.10 in controls. The ordinal OR was 0.59 for each variant allele (95% CI 0.41-0.84), and this association was similar for CLL/SLL (OR=0.58; 95% CI 0.32-1.02), follicular lymphoma (OR=0.58; 95% CI 0.32-1.05), and DLBCL (OR=0.56; 95% CI 0.26-1.20)
  1994.  
  1995. 004: 3q; NISCH (CC;) Position: 52506426
  1996. \Citations: https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6784615
  1997. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  1998. >aEffect Allele: WHR increasing allele on the forward strand;
  1999. >NISCH, EA = T
  2000.  
  2001. 005: 8q; NRG1 (CC;) Position: 32168933
  2002. \https://www.snpedia.com/index.php/Rs10093107
  2003. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040109/table/T1/?report=objectonly
  2004.  
  2005. 005b: 8q; NRG1 (CC;) Position: 32039076
  2006. \https://www.snpedia.com/index.php/Rs1462906
  2007. \https://www.ncbi.nlm.nih.gov/m/pubmed/21179114/
  2008.  
  2009. 005c: 8q; NRG1 (TT;) Position: 32553698
  2010. \https://www.snpedia.com/index.php/Rs16879552
  2011. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024406/table/pone-0016181-t001/?report=objectonly
  2012.  
  2013. 005d: 8q; NRG1 (TT;) Position: 31638065
  2014. \https://www.ncbi.nlm.nih.gov/m/pubmed/19594860/
  2015. \https://www.ncbi.nlm.nih.gov/m/pubmed/17925794/
  2016.  
  2017. 006: 14q; NRXN3 (GG;) Position: 79945162
  2018. \http://www.pdgene.org/view?poly=rs10146997
  2019. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419359/table/T3/
  2020.  
  2021. O
  2022.  
  2023. 001: 15q; OCA2 (GG;) Position: 27752101
  2024. \https://www.snpedia.com/index.php/Rs17565841
  2025. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=17565841
  2026. >Frequency, CEU = (A=0.016, G=0.816,) YRI = (A=0.05, G=0.94)
  2027. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758866/#!po=28.8462
  2028. >Genomewide association study for onset age in Parkinson disease
  2029. >The most highly associated SNP in both the additive and dominant three sample meta-analyses, rs17565841, is located approximately 3 kb from the 3' end of the gene OCA2 on chromosome 15 [...] This SNP was associated with an average 2.8 years younger onset age (p = 2.6 × 10-6) under an additive model and a 3.3 years younger onset age (p = 2.1 × 10-6) under a dominant model
  2030. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758866/table/T2/?report=objectonly
  2031. >SNP = rs17565841, Minor allele = A
  2032.  
  2033. 001b: 15q; OCA2 (GG;) Position: 28099092
  2034. \https://www.snpedia.com/index.php/Rs7495174
  2035. \https://www.ncbi.nlm.nih.gov/m/pubmed/17952075/
  2036. >Blue versus brown eyes = rs7495174-A = Discovery OR(6.9,) Replication OR(5.56,) Netherlands OR(4.87) [...] Blue versus green eyes = rs7495174-A = Discovery OR(1.41,) Replication OR(2.02,) Netherlands OR(1.45) [...] Red versus non-red hair = rs7495174-A = Discovery OR(1.49,) Replication OR(1.26,) Netherlands OR(1.15) [...] Blond versus brown hair = rs7495174-A = Discovery OR(4.94,) Replication OR(5.96,) Netherlands OR(5.51)
  2037.  
  2038. 001c: 15q; OCA2 (TT;) Position: 28093567
  2039. \https://www.snpedia.com/index.php/Rs4778241
  2040. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427173/
  2041. \The highest association for blue:nonblue (green/hazel or brown) eye color was found with three SNPs in intron 1: rs7495174 T/C, rs6497268 (now rs4778241) G/T, and rs11855019 (now rs4778138) T/C. We found the TGT/TGT diplotype in 62.2% of samples, and this was the major blue-eye genotype, with a frequency of 91% in blue- or green-eyed individuals, compared with only 9.5% in those with brown eyes
  2042.  
  2043. 001d: OCA2 (CC;) Position: 28090674
  2044. \https://www.snpedia.com/index.php/Rs4778138
  2045. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427173/
  2046. \The highest association for blue:nonblue (green/hazel or brown) eye color was found with three SNPs in intron 1: rs7495174 T/C, rs6497268 (now rs4778241) G/T, and rs11855019 (now rs4778138) T/C. We found the TGT/TGT diplotype in 62.2% of samples, and this was the major blue-eye genotype, with a frequency of 91% in blue- or green-eyed individuals, compared with only 9.5% in those with brown eyes
  2047.  
  2048. 001e: OCA2 (CC;) Position: 28082689
  2049. \https://www.snpedia.com/index.php/Rs4778137
  2050. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4778137
  2051. >Frequency = CEU(C=0.465, G=0.534,) HCB(CC=0.04, CG=0.24, GG=0.711,) JPT(CC=0.681, CG=0.272, GG=0.659,) YRI(CC=0.101, CG=0.508, GG=0.389)
  2052. \https://www.ncbi.nlm.nih.gov/m/pubmed/20308648/
  2053. >Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival
  2054. >the rare G allele being associated with increased overall survival (HR of death per rare allele carried = 0.56
  2055.  
  2056. 002: Xq; OPN1LW (TT;) Position: 154154734
  2057. \https://www.snpedia.com/index.php/Rs104894912
  2058. \https://www.omim.org/entry/300822#1
  2059. >BLUE CONE MONOCHROMACY [...] In the male proband from a 4-generation BCM family with 3 affected individuals, who had been previously studied by Reitner et al. (1991) (patient 'MP'), Nathans et al. (1993) identified a single red pigment gene carrying a C-T transition in exon 4, resulting in an arg247-to-ter (R247X) substitution
  2060.  
  2061. 002b: Xq; OPN1LW (AA;) Position: 154158844
  2062. \https://www.snpedia.com/index.php/Rs104894913
  2063. \https://www.omim.org/entry/300822#4
  2064. >COLORBLINDNESS, PROTAN [...] In a person with protan colorblindness (CBP; 303900), Ueyama et al. (2002) found a gly338-to-glu (GGG to GAG; G338E) mutation in the single red pigment gene. The mutant opsin showed no absorbance
  2065.  
  2066. 002c: Xq; OPN1LW (CC;) Position: 154154602
  2067. \https://www.snpedia.com/index.php/Rs121434621
  2068. \https://www.omim.org/entry/300822#3
  2069. >BLUE CONE MONOCHROMACY [...] In the male proband from a 3-generation family with 8 individuals with blue cone monochromacy (BCM; 303700), Nathans et al. (1993) identified a cys203-to-arg (C203R) mutation
  2070. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=121434621
  2071. >T(T, Cys) -> C(R, Arg)
  2072.  
  2073. 003: Xq; OPN1MW (CC;) Position: 154191716
  2074. \https://www.snpedia.com/index.php/Rs104894914
  2075. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104894914
  2076. >T(T, Cys) -> C(R, Arg)
  2077. \https://www.omim.org/entry/300821#1
  2078. >DEUTERANOMALY [...] Jagla et al. (2002) observed the C203R mutation among 5 of 50 multigene deuteranopes (see 303800) of middle European ancestry, suggesting a founder effect for this mutation
  2079.  
  2080. 003b: Xq; OPN1MW (AA;) Position: 154187939
  2081. \https://www.snpedia.com/index.php/Rs104894915
  2082. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104894915
  2083. \https://www.omim.org/entry/300821#3
  2084. >In a Japanese subject with deutan colorblindness (CBD; 303800), Ueyama et al. (2002) found an asn94-to-lys (AAC to AAA) missense mutation in the single green pigment gene
  2085.  
  2086. 003c: Xq; OPN1MW (AA;) Position: 154195934
  2087. \https://www.snpedia.com/index.php/Rs104894916
  2088. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104894916
  2089. \https://www.omim.org/entry/300821#4
  2090. >In a Japanese male with deutan colorblindness (CBD; 303800), Ueyama et al. (2002) found an arg330-to-gln (CGA to CAA) mutation in both green pigment genes
  2091.  
  2092. 003d: Xq; OPN1MW (CC;) Position: 154190173
  2093. \https://www.snpedia.com/index.php/Rs267606927
  2094. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=267606927
  2095. >T(W, Trp) -> C(R, Arg)
  2096. \https://www.omim.org/entry/300821#6
  2097. >CONE DYSTROPHY 5, X-LINKED [...] long-range PCR and sequence analysis in a 3-generation British family with X-linked cone dystrophy mapping to Xq27.3 (see 303700), Gardner et al. (2010) demonstrated that the cone opsin gene array in affected members consisted of an LW gene containing a 529T-C transition in an MW exon 3, resulting in a trp177-to-arg (W177R) substitution at a highly conserved residue, followed by an MW gene containing an identical W177R mutation in exon 3
  2098.  
  2099. 003e: Xq; OPN1MW (CC;) Position: 154182566
  2100. \https://www.snpedia.com/index.php/Rs724159983
  2101. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=724159983
  2102. >Contig allele = A
  2103. \https://www.omim.org/entry/300821#5
  2104. >COLORBLINDNESS, DEUTAN [...] In 32 of 37 (86.5%) Japanese subjects with deutan colorblindness (CBD; 303800) and a normal genotype, Ueyama et al. (2003) identified a -71A-C transversion in the green pigment gene at the second position in the array
  2105.  
  2106. 004: 7q; OPN1SW (AA;) Position: 128775556
  2107. \https://www.snpedia.com/index.php/Rs104894031
  2108. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104894031
  2109. \https://www.omim.org/entry/613522#1
  2110. >In 4 individuals with tritanopia (190900), Weitz et al. (1992) identified a 644G-A transition in the BCP gene, resulting in a gly79-to-arg (G79R) substitution in the second transmembrane domain of the blue-sensitive opsin
  2111.  
  2112. 004b: 7q; OPN1SW (CC;) Position: 128774545
  2113. \https://www.snpedia.com/index.php/Rs104894032
  2114. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104894032
  2115. >T(S, Ser) -> C(P, Pro)
  2116. \https://www.omim.org/entry/613522#2
  2117. >In an individual with tritanopia (190900), Weitz et al. (1992) identified a 1049C-T transition in exon 3 of the BCP gene, resulting in a ser214-to-pro (S214P) substitution in the fifth transmembrane domain of the blue-sensitive opsin
  2118.  
  2119. 004c: 7q; OPN1SW (TT;) Position: 128773786
  2120. \https://www.snpedia.com/index.php/Rs104894033
  2121. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104894033
  2122. >C(P, Pro) -> T(S, Ser)
  2123. \https://www.omim.org/entry/613522#3
  2124. >In 3 unrelated persons with tritanopia (190900), Weitz et al. (1992) identified a 1199C-T transition in the BCP gene, resulting in the substitution of serine for proline-264 (P264S
  2125.  
  2126. 005: 3q; OXTR (TT;) Position: 8752859
  2127. \https://www.snpedia.com/index.php/Rs1042778
  2128. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1042778
  2129. >Frequency = CEU(GG=0.398, GT=0.469, TT=0.132,) YRI(GG=0.08, GT=0.482, TT=0.437,) HCB(GG=0.88, GT=0.119, TT=0.0)
  2130. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187267/#!po=14.7959
  2131. >the G allele of the OXTR rs1042778 were each implicated in prosocial decision making (Israel et al., 2009), and carriers of the rs1042778 G allele exhibited more parenting behaviour and had higher plasma OT levels than T carriers
  2132. \http://www.sciencedirect.com/science/article/pii/S0091305711001985
  2133. >The post hoc analysis revealed that only the QNP-treated males spent more time in close contact with the scented male relative to the unscented (novel) male
  2134. >OT (Oxytocin) receptor antagonists block partner preferences induced by D2-type receptor agonists like QNP
  2135. \http://www.sciencedirect.com/science/article/pii/S0006322309007628
  2136. >oxytocin increased the envy ratings [...] Oxytocin also increased the ratings of gloating
  2137. \https://www.sciencedirect.com/science/article/pii/S0306453013003326
  2138. >Results indicate that homosexual in comparison to heterosexual men display higher sensitivity to oxytocin's enhancing impact on social approach tendencies
  2139. \https://en.wikipedia.org/wiki/Quinpirole
  2140. >At least one study has found that quinpirole induces compulsive behavior symptomatic of obsessive compulsive disorder in rats
  2141.  
  2142. 005b: 3q; OXTR (CC;) Position: 8761057
  2143. \https://www.snpedia.com/index.php/Rs13316193
  2144. \https://www.ncbi.nlm.nih.gov/m/pubmed/20347913/
  2145. >Additionally, significant association was also found for rs13316193 (F=3.09, p=0.05) with post-hoc tests demonstrating that the CC genotype was significantly associated with poorer social ability than the TT genotype
  2146.  
  2147. 005c: 3q; OXTR (TT;) Position: 8755399
  2148. \https://www.snpedia.com/index.php/Rs2268490
  2149. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2268490
  2150. >Frequency = CEU(CC=0.761, CT=0.238,) HCB(CC=0.325, CT=0.511, TT=0.162,) YRI(CC=0.557, CT=0.389, TT=0.05)
  2151. \https://www.ncbi.nlm.nih.gov/m/pubmed/23547247/
  2152. >C-rs2268490) was associated with lower levels of post-betrayal satisfaction
  2153.  
  2154. 005d: 3q; OXTR (TT;) Position: 8760360
  2155. \https://www.snpedia.com/index.php/Rs2268494
  2156. \https://www.ncbi.nlm.nih.gov/m/pubmed/23547247/
  2157. >T-rs2268494) was significantly associated with faster retaliation post-betrayal
  2158.  
  2159. 005e: 3q; OXTR (AA;) Position: 8755356
  2160. \https://www.snpedia.com/index.php/Rs237887
  2161. \https://www.ncbi.nlm.nih.gov/m/pubmed/23547247/
  2162. >A-rs237887 [...] was associated with higher levels of post-betrayal satisfaction
  2163.  
  2164. 005f: 3q; OXTR (AA;) Position: 8762685
  2165. \https://www.snpedia.com/index.php/Rs53576
  2166. \https://www.ncbi.nlm.nih.gov/m/pubmed/19934046/
  2167. >Compared with individuals homozygous for the G allele of rs53576 (GG), individuals with one or two copies of the A allele (AG/AA) exhibited lower behavioral and dispositional empathy
  2168.  
  2169. P
  2170.  
  2171. 001: 2q; PAX3 (TT;) Position: 222272282
  2172. \https://www.snpedia.com/index.php/Rs12995399
  2173. \https://www.ncbi.nlm.nih.gov/pubmed/23751107?dopt=Abstract
  2174.  
  2175. 001b: 2q; PAX3 (CC;) Position: 222202200
  2176. \https://www.snpedia.com/index.php/Rs2855268
  2177. \https://www.ncbi.nlm.nih.gov/pubmed/23751107?dopt=Abstract
  2178.  
  2179. 001c: 2q; PAX3 (TT;) Position: 222297305
  2180. \https://www.snpedia.com/index.php/Rs6754024
  2181. \https://www.ncbi.nlm.nih.gov/pubmed/23751107?dopt=Abstract
  2182.  
  2183. 001d: 2q; PAX3 (AA;) Position: 222203567
  2184. \https://www.snpedia.com/index.php/Rs7559271
  2185. \https://www.ncbi.nlm.nih.gov/pubmed/22341974?dopt=Abstract
  2186.  
  2187. 001e: 2q; PAX3 (TT;) Position: 222291868
  2188. \https://www.snpedia.com/index.php/Rs7600206
  2189. \https://www.ncbi.nlm.nih.gov/pubmed/23751107?dopt=Abstract
  2190.  
  2191. 002: 11q; PAX6 (CC;) Position: 31809109
  2192. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3026354
  2193. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2194. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2195.  
  2196. 002b: 11q; PAX6 (CC;) Position: 31793814
  2197. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=667773
  2198. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2199. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2200.  
  2201. 002c: 11q; PAX6 (AA;) Position: 31791961
  2202. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3026390
  2203. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2204. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2205.  
  2206. 002d: 11q; PAX6 (GG;) Position: 31791034
  2207. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2071754
  2208. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2209. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2210.  
  2211. 002e: 11q; PAX6 (TT;) Position: 31790667
  2212. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3026393
  2213. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2214. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2215.  
  2216. 002f: 11q; PAX6 (AA;) Position: 31788750
  2217. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1506
  2218. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2219. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2220.  
  2221. 002g: 11q; PAX6 (GG;) Position: 31787774
  2222. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=12421026
  2223. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2224. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2225.  
  2226. 002h: 11q; PAX6 (GG;) Position: 31787522
  2227. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=662702
  2228. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2229. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2230.  
  2231. 002i: 11q; PAX6 (AA;) Position:
  2232. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3026401
  2233. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2234. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2235.  
  2236. 002j: 11q; PAX6 (GG:) Position: 31778325
  2237. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7125966
  2238. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2239. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2240.  
  2241. 002k: 11q; PAX6 (GG;) Position: 31657400
  2242. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=964112
  2243. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2244. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2245.  
  2246. 002l: 11q; PAX6 (AA;) Position: 31584349
  2247. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11031419
  2248. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2249. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2250.  
  2251. 002m: 11q; PAX6 (TT;) Position: 31513808
  2252. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=509628
  2253. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/
  2254. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093386/table/pone-0019587-t002/?report=objectonly
  2255.  
  2256. 003: 20q; PDYN (TT;) Position: 1994212
  2257. \https://www.snpedia.com/index.php/Rs1997794
  2258. \https://link.springer.com/article/10.1007%2Fs00702-009-0238-5
  2259. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1997794
  2260.  
  2261. 003b: 20q; PDYN (AA;) Position: 1979580
  2262. \https://www.snpedia.com/index.php/Rs910080
  2263. \http://onlinelibrary.wiley.com/store/10.1111/j.1601-183X.2012.00785.x/asset/j.1601-183X.2012.00785.x.pdf?v=1&t=j7b8zk9p&s=63a99164dd7bcd367abf3602ac245547c640a0a0
  2264.  
  2265. 003c: 20q; PDYN (GG;) Position: 1979293
  2266. \https://www.snpedia.com/index.php/Rs2235749
  2267. \https://www.ncbi.nlm.nih.gov/pubmed/27074815?dopt=Abstract
  2268.  
  2269. 003d: 20q; PDYN (AA;) Position: 1989288
  2270. \https://www.snpedia.com/index.php/Rs2235751
  2271. \https://www.ncbi.nlm.nih.gov/pubmed/19468819?dopt=Abstract
  2272.  
  2273. 004: 17q; PEMT (TT;) Position: 17439793
  2274. \Citations: http://www.pdgene.org/view?poly=rs936108
  2275. \https://academic.oup.com/hmg/article/23/9/2498/632550/Gene-centric-meta-analyses-for-central-adiposity
  2276. \was associated with increased WHR [...] as was [...] rs936108-C in PEMT
  2277.  
  2278. 005: 16q; PRSS53 (CC;) Position: 31087690
  2279. \https://www.snpedia.com/index.php/Rs11150606
  2280. \http://dx.doi.org/10.1038/ncomms10815
  2281.  
  2282. 006: 1q; PROX1 (GG;) Position: 213985643
  2283. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340875
  2284. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2285. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2286. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2287.  
  2288. 006b: 1q; PROX1 (TT;) Position: 213987186
  2289. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340874
  2290. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2291. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2292. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2293.  
  2294. 006c: 1q; PROX1 (GG;) Position: 213987186
  2295. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340873
  2296. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2297. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2298. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2299.  
  2300. 006d: 1q; PROX1 (TT;) Position: 213987205
  2301. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340872
  2302. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2303. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2304. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2305.  
  2306. 006e: 1q; PROX1 (AA;) Position: 213988477
  2307. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340839
  2308. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2309. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2310. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2311.  
  2312. 006f: 1q; PROX1 (TT;) Position: 213989230
  2313. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340838
  2314. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2315. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2316. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2317.  
  2318. 006g: 1q; PROX1 (GG;) Position: 213989391
  2319. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340837
  2320. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2321. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2322. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2323.  
  2324. 006h: 1q; PROX1 (CC;) Position: 213989726
  2325. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340836
  2326. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2327. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2328. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2329.  
  2330. 006i: 1q; PROX1 (GG;) Position: 213990332
  2331. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=340835
  2332. \http://diabetes.diabetesjournals.org/content/62/5/1738#F1
  2333. \http://diabetes.diabetesjournals.org/content/diabetes/62/5/1738/F2.large.jpg?width=800&height=600&carousel=1
  2334. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298567/
  2335.  
  2336. 006: 9q; PTCH1 (TT;) Position: 95479134
  2337. \https://www.snpedia.com/index.php/Rs199476090
  2338. \https://www.omim.org/entry/601309#0003
  2339.  
  2340. 006b: 9q; PTCH1 (GAGA;) Position: 87864514
  2341. \https://www.snpedia.com/index.php/Rs1057524874
  2342. \https://www.ncbi.nlm.nih.gov/m/pubmed/27426521/
  2343.  
  2344. 007: 2q; PTH2R (GG;) Position: 208477369
  2345. \https://www.snpedia.com/index.php/Rs897083
  2346. \https://www.ncbi.nlm.nih.gov/pubmed/24378925?dopt=Abstract
  2347.  
  2348. 008: 20q; PTGIS (TT;) Position: 49505441
  2349. \https://www.snpedia.com/index.php/Rs5602
  2350. \https://www.ncbi.nlm.nih.gov/m/pubmed/27186408/
  2351. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27215/#!po=11.5854
  2352.  
  2353. 008b: 20q; PTGIS (CC;) Position: 49513169
  2354. \https://www.snpedia.com/index.php/Rs5629
  2355. \https://www.ncbi.nlm.nih.gov/m/pubmed/19147528/
  2356. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929860/
  2357.  
  2358. 009: 12q; PTPRQ (CC;) Position: 80506078
  2359. \https://www.snpedia.com/index.php/Rs147541734
  2360. \https://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=147541734
  2361.  
  2362. 009b: 12q; PTPRQ (TT;) Position: 80460829
  2363. \https://www.snpedia.com/index.php/Rs183258549
  2364. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=183258549
  2365. \https://www.ncbi.nlm.nih.gov/clinvar/variation/156333/
  2366.  
  2367. 009c: 12q; PTPRQ (GG;) Position: 80539915
  2368. \https://www.snpedia.com/index.php/Rs190166486
  2369. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=190166486
  2370.  
  2371. 009d: 12q; PTPRQ (GG;) Position: 80460707
  2372. \https://www.snpedia.com/index.php/Rs281865414
  2373. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=281865414
  2374. \https://www.ncbi.nlm.nih.gov/clinvar/variation/156332/
  2375.  
  2376. 009e: 12q; PTPRQ (-A;) Position: 80669467
  2377. \https://www.snpedia.com/index.php/Rs749210663
  2378. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=749210663
  2379.  
  2380. Q
  2381. R
  2382.  
  2383. 001: 1q; RHD (CC;) Position: 25303452
  2384. \https://www.snpedia.com/index.php/Rs590787
  2385. \http://www.biorxiv.org/content/biorxiv/suppl/2017/07/30/164400.DC2/164400-1.pdf
  2386. \pp69, bloodtype
  2387.  
  2388. 002: 22q; RTN4R (AA;) Position: 20242546
  2389. \https://www.snpedia.com/index.php/Rs74315509
  2390. \http://www.omim.org/entry/605566#0002
  2391.  
  2392. 002b: 22q; RTN4R (TT;) Position: 20242778
  2393. \https://www.snpedia.com/index.php/Rs74315508
  2394. \http://www.omim.org/entry/605566#0001
  2395.  
  2396. 002c: 22q; RTN4R (GG;) Position: 20241019
  2397. \https://www.snpedia.com/index.php/Rs701428
  2398. \https://www.ncbi.nlm.nih.gov/pubmed/28139055?dopt=Abstract
  2399.  
  2400. 003: 6q; RSPO3 (CC;) Position: 127452639
  2401. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=9491696
  2402. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  2403. >aEffect Allele: WHR increasing allele on the forward strand;
  2404. >RSPO3, EA = G
  2405.  
  2406. 004: 6q; RUNX2 (CC;) Position: 45421552
  2407. \https://www.snpedia.com/index.php/Rs7771980
  2408. \http://journals.plos.org/plosone/article/file?type=supplementary&id=info:doi/10.1371/journal.pone.0083218.s009
  2409.  
  2410. 004b: 6q; RUNX2 (AA;) Position: 45512277
  2411. \https://www.snpedia.com/index.php/Rs104893988
  2412. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104893988
  2413. \http://www.omim.org/entry/600211#2
  2414.  
  2415. S
  2416.  
  2417. 001: 11q; SBF2 (TT;) Position: 10207181
  2418. \https://www.snpedia.com/index.php/Rs1867138
  2419. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667283/
  2420.  
  2421. 002: 2q; SCN9A (GG;) Position: 166286562
  2422. \https://www.snpedia.com/index.php/Rs121908908
  2423. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=121908908
  2424. \http://www.omim.org/entry/603415#0005
  2425.  
  2426. 002b: 2q; SCN9A (AA;) Position: 166277133
  2427. \https://www.snpedia.com/index.php/Rs121908909
  2428. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=121908909
  2429. \http://www.omim.org/entry/603415#0007
  2430.  
  2431. 002c: 2q; SCN9A (TT;) Position: 166303162
  2432. \https://www.snpedia.com/index.php/Rs121908916
  2433. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=121908916
  2434. \http://www.omim.org/entry/603415#0014
  2435.  
  2436. 002d: 2q; SCN9A (AA;) Position: 166293354
  2437. \https://www.snpedia.com/index.php/Rs121908917
  2438. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=121908917
  2439. \http://www.omim.org/entry/603415#0015
  2440.  
  2441. 003: 7q; SDK1 (GG;) Position: 4150281
  2442. \https://www.snpedia.com/index.php/Rs645106
  2443. \https://www.ncbi.nlm.nih.gov/m/pubmed/19851296/
  2444.  
  2445. 004: 17q; SHBG (AA;) Position: 7630105
  2446. \https://www.snpedia.com/index.php/Rs1799941
  2447. \https://www.ncbi.nlm.nih.gov/pubmed/19574343?dopt=Abstract
  2448.  
  2449. 004b: 17q; SHBG (TT;) Position: 7631360
  2450. \https://www.snpedia.com/index.php/Rs6258
  2451. \http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1002313
  2452.  
  2453. 005: 1q; SHC1 (GG;) Position: 154944156
  2454. \Citations: http://www.pdgene.org/view?poly=rs12076073
  2455. \https://academic.oup.com/hmg/article/23/9/2498/632550/Gene-centric-meta-analyses-for-central-adiposity
  2456. \rs12076073-A in SHC1 (frequency = 0.96) increased WHR by 0.101 units (SE = 0.021) among females
  2457.  
  2458. 006: 10q; SIRT1 (TT;) Position: 67883584
  2459. \https://www.snpedia.com/index.php/Rs3758391
  2460. \https://www.ncbi.nlm.nih.gov/m/pubmed/17895433/
  2461.  
  2462. 006b: 10q; SIRT1 (CC;) Position: 67917073
  2463. \https://www.snpedia.com/index.php/Rs4746720
  2464. \https://www.ncbi.nlm.nih.gov/m/pubmed/20633545/
  2465.  
  2466. 007: 12q; SLC15A4 (CC;) Position: 128793765
  2467. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3765107
  2468. \http://www.cell.com/cell/fulltext/S0092-8674(17)30128-9
  2469. \http://www.cell.com/action/showFullTableImage?isHtml=true&tableId=tbl1&pii=S0092867417301289
  2470.  
  2471. 008: 14q; SLC24A4 (CC;) Position: 92307319
  2472. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=12896399
  2473. \https://www.ncbi.nlm.nih.gov/m/pubmed/17952075/
  2474. >Blue versus brown eyes = rs12896399-T = Discovery OR(1.15,) Replication OR(1.29,) Netherlands OR(1.12) [...] Blue versus green eyes = rs12896399-T = Discovery OR(2.06,) Replication OR(1.49,) Netherlands OR(2.08) [...] Red versus non-red hair = rs12896399-T = Discovery OR(1.06,) Replication OR(1.07,) Netherlands OR(0.88) [...] Blond versus brown hair = rs12896399-T = Discovery OR(2.56,) Replication OR(2.34,) Netherlands OR(1.86)
  2475.  
  2476. 009: 15q; SLC24A5 (AA;) Position: 48134287
  2477. \https://www.snpedia.com/index.php/Rs1426654
  2478. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1426654
  2479.  
  2480. 009b: 15q; SLC24A5 (AA;) Position: 48124702
  2481. \https://www.snpedia.com/index.php/Rs16960620
  2482. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=16960620
  2483.  
  2484. 009c: 15q; SLC24A5 (GG;) Position: 48127189
  2485. \https://www.snpedia.com/index.php/Rs2555364
  2486. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2555364
  2487.  
  2488. 010: 5q; SLC45A2 (CC;) Position: 33986304
  2489. \https://www.snpedia.com/index.php/Rs13289
  2490. \https://www.ncbi.nlm.nih.gov/m/pubmed/17358008/
  2491.  
  2492. 010b: 5q; SLC45A2 (GG;) Position: 33951588
  2493. \https://www.snpedia.com/index.php/Rs16891982
  2494. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=16891982
  2495. >TTC(F, Phe) -> TTG(L, Leu) [...] Frequency = CEU(C=0.03, G=0.96,) YRI = (C=1.0, G=0.0)
  2496. \https://www.ncjrs.gov/pdffiles1/nij/grants/223980.pdf
  2497. >Six markers have significant effects on hair total melanin: dbSNP rs16891982 (MATP) (SLC45A2,) [...] When each are considered separately, these markers account for 57.8% [...] (respectively) of the total trait variation
  2498. \https://www.ncbi.nlm.nih.gov/m/pubmed/18806926/
  2499. >the L374 allele is ancestral [...] Fernandez et al. (2008) also observed that the L374 allele is linked with darker pigmentation
  2500.  
  2501. 010c: 5q; SLC45A2 (CC;) Position: 33963765
  2502. \https://www.snpedia.com/index.php/Rs26722
  2503. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=26722
  2504.  
  2505. 010d: 5q; SLC45A2 (AA;) Position: 33955221
  2506. \https://www.snpedia.com/index.php/Rs35390
  2507. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=35390
  2508.  
  2509. 010e: 5q; SLC45A2 (CC;) Position: 33955568
  2510. \https://www.snpedia.com/index.php/Rs35391
  2511. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=35391
  2512.  
  2513. 010f: 5q; SLC45A2 (CC;) Position: 33969523
  2514. \https://www.snpedia.com/index.php/Rs35414
  2515. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=35414
  2516.  
  2517. 011: 5q; SLC6A3 (9T/9T;) Position: 1411740
  2518. \https://www.snpedia.com/index.php/Rs3836790
  2519. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414865/#!po=26.5432
  2520.  
  2521. 011b: 5q; SLC6A3 (CC;) Position: 1432710
  2522. \https://www.snpedia.com/index.php/Rs460000
  2523. \https://www.ncbi.nlm.nih.gov/m/pubmed/20091113/
  2524.  
  2525. 012: 17q; SLC6A4 (GG;) Position: 30197993
  2526. \https://www.snpedia.com/index.php/Rs1042173
  2527. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657929/figure/F3/?report=objectonly
  2528.  
  2529. 012b: 17q; SLC6A4 (AA;) Position: 30211514
  2530. \https://www.snpedia.com/index.php/Rs140701
  2531. \https://www.ncbi.nlm.nih.gov/m/pubmed/18663369/
  2532.  
  2533. 012c: 17q; SLC6A4 (AA;) Position: 30237328
  2534. \https://www.snpedia.com/index.php/Rs25531
  2535. \https://www.ncbi.nlm.nih.gov/m/pubmed/20090673/
  2536.  
  2537. 012d: 17q; SLC6A4 (TT;) Position: 30237152
  2538. \https://www.snpedia.com/index.php/Rs25532
  2539. \https://www.ncbi.nlm.nih.gov/m/pubmed/18055562/
  2540.  
  2541. 012e: 17q; SLC6A4 (AA;) Position: 30204775
  2542. \https://www.snpedia.com/index.php/Rs3794808
  2543. \https://www.ncbi.nlm.nih.gov/m/pubmed/18663369/
  2544.  
  2545. 012f: 17q; SLC6A4 (GG;) Position: 30211697
  2546. \https://www.snpedia.com/index.php/Rs4583306
  2547. \https://www.ncbi.nlm.nih.gov/m/pubmed/18663369/
  2548.  
  2549. 013: 5q; SRD5A1 (GG;) Position: 6633779
  2550. \Citations: http://www.pdgene.org/view?poly=rs248793
  2551. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083475/#!po=14.1791
  2552. \For SRD5A1, the exon 1 synonymous SNP rs248793 (G>C) has been associated with the ratio of dihydrotestosterone to testosterone, such that individuals homozygous for the minor C-allele had a higher ratio than G-allele homozygotes and heterozygote
  2553.  
  2554. 014: 2q; SRD5A2 (GG;) Position: 31580823
  2555. \https://www.snpedia.com/index.php/Rs104893667
  2556. \https://www.ncbi.nlm.nih.gov/clinvar/variation/3350/
  2557.  
  2558. 014b: 2q; SRD5A2 (TT;) Position: 31567511
  2559. \https://www.snpedia.com/index.php/Rs13395648
  2560. \https://www.ncbi.nlm.nih.gov/pubmed/22735779?dopt=Abstract
  2561.  
  2562. 015: 17q; SSTR2 (CC;) Position: 73169179
  2563. \https://www.snpedia.com/index.php/Rs1466113
  2564. \https://www.ncbi.nlm.nih.gov/pubmed/20948194?dopt=Abstract
  2565.  
  2566. 016: 3q; SYN2 (CC;) Position: 12167171
  2567. \https://www.snpedia.com/index.php/Rs795009
  2568. \https://www.ncbi.nlm.nih.gov/m/pubmed/15449241/
  2569.  
  2570. T
  2571.  
  2572. 001: 1q; TAS1R3 (TT;) Position: 1334174
  2573. \https://www.snpedia.com/index.php/Rs307377
  2574. \https://www.ncbi.nlm.nih.gov/m/pubmed/19587085/
  2575.  
  2576. 002: 1q; TAS2R38 (GG;) Position: 141973545
  2577. \https://www.snpedia.com/index.php/Rs713598
  2578. \https://www.ncbi.nlm.nih.gov/m/pubmed/21763010/
  2579.  
  2580. 002b: 1q; TAS2R38 (TT;) Position: 141972905
  2581. \https://www.snpedia.com/index.php/Rs1726866
  2582. \http://omim.org/entry/607751
  2583.  
  2584. 002c: 1q; TAS2R38 (TT;) Position: 141972905
  2585. \https://www.snpedia.com/index.php/Rs1726866
  2586. \https://www.ncbi.nlm.nih.gov/m/pubmed/19782709/
  2587.  
  2588. 003: 1q; TBX15 (CC;) Position: 119503843
  2589. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=984222
  2590. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  2591. >aEffect Allele: WHR increasing allele on the forward strand;
  2592. >TBX15, EA = G
  2593.  
  2594. 003b: 1q; TBX15 (CC;) Position: 118884844
  2595. \https://www.snpedia.com/index.php/Rs61730011
  2596. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302847/table/T2/?report=objectonly
  2597. >Low-frequency variants associated with adult height [...] The direction of the effect (Beta, standard deviation units) and effect allele frequency (AF) is given for the alternate (Alt) allele
  2598. >rs61730011, Ref/Alt:A/C , TBX15, Alt = C, Beta = -0.059
  2599.  
  2600. 004: 10q; TCF7L2 (GG;) Position: 113047288
  2601. \https://www.snpedia.com/index.php/Rs11196205
  2602. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618330/#!po=56.6667
  2603.  
  2604. 004b: 10q; TCF7L2 (GG;) Position: 113049143
  2605. \https://www.snpedia.com/index.php/Rs12255372
  2606. \https://www.ncbi.nlm.nih.gov/m/pubmed/25185411/
  2607.  
  2608. 004c: 10q; TCF7L2 (AA;) Position: 112971038
  2609. \https://www.snpedia.com/index.php/Rs12573128
  2610. \https://www.ncbi.nlm.nih.gov/m/pubmed/28404897/
  2611.  
  2612. 004d: 10q; TCF7L2 (GG;) Position: 113041766
  2613. \https://www.snpedia.com/index.php/Rs7895340
  2614. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7895340
  2615.  
  2616. 004e: 10q; TCF7L2 (TT;) Position: 112998590
  2617. \https://www.snpedia.com/index.php/Rs7903146
  2618. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266211/table/Tab3/
  2619.  
  2620. 005: 1q; TCHH (TT;) Position: 152110849
  2621. \https://www.snpedia.com/index.php/Rs11803731
  2622. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775823/figure/fig1/?report=objectonly
  2623. \With more T alleles, the proportion of straight hair increases
  2624.  
  2625. 006: 5q; TERT (GG;) Position: 1297373
  2626. \https://www.snpedia.com/index.php/Rs2736108
  2627. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174246/
  2628.  
  2629. 006b: 5q; TERT (GG;) Position: 1296644
  2630. \https://www.snpedia.com/index.php/Rs2736109
  2631. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174246/
  2632.  
  2633. 006c: 5q; TERT (AA;) Position: 1288432
  2634. \https://www.snpedia.com/index.php/Rs2853676
  2635. \https://www.ncbi.nlm.nih.gov/m/pubmed/26042809/
  2636.  
  2637. 006d: 5q; TERT (AA;) Position: 1285859
  2638. \https://www.snpedia.com/index.php/Rs7705526
  2639. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670748/
  2640. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7705526
  2641.  
  2642. 006e: 6q; TFAP2B (AG;) Position: 50803050
  2643. \Citations: http://www.pdgene.org/view?poly=rs987237
  2644. \http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110388/?report=classic
  2645.  
  2646. 007: 19q; TGFB1 (TT;) Position: 41353016
  2647. \https://www.snpedia.com/index.php/Rs1800470
  2648. \https://www.ncbi.nlm.nih.gov/m/pubmed/16807529/
  2649. \http://iovs.arvojournals.org/article.aspx?articleid=2124443
  2650.  
  2651. 008: 1q; TGFB2 (CC;) Position: 218442109
  2652. \https://www.snpedia.com/index.php/Rs991967
  2653. \https://www.ncbi.nlm.nih.gov/m/pubmed/19710942/
  2654. \http://iovs.arvojournals.org/article.aspx?articleid=2124443
  2655.  
  2656. 009: 11q; TH (TT;) Position: 2172610
  2657. \https://www.ncbi.nlm.nih.gov/m/pubmed/24417771/
  2658.  
  2659. 010: 3q; TMCC1 (CC;) Position: 129582884
  2660. \Citations: http://www.pdgene.org/view?poly=rs2811337
  2661. \https://academic.oup.com/hmg/article/23/9/2498/632550/Gene-centric-meta-analyses-for-central-adiposity
  2662. \rs2811337-G near TMCC1 was associated with increased WHR
  2663.  
  2664. 011: 17q; TP53 (CC;) Position: 7676154
  2665. \https://www.snpedia.com/index.php/Rs1042522
  2666. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118619/
  2667.  
  2668. 012: 11q; TPCN2 (AA;) Position: 69078931
  2669. \https://www.snpedia.com/index.php/Rs35264875
  2670. \http://omim.org/entry/612163
  2671.  
  2672. 012b: 11q; TPCN2 (AA;) Position: 69087895
  2673. \https://www.snpedia.com/index.php/Rs3829241
  2674. \http://omim.org/entry/612163
  2675.  
  2676. 013: 11q; TPH1 (AA;) Position: 18068882
  2677. \http://www.pdgene.org/view?poly=rs4537731
  2678. \http://pubmedcentralcanada.ca/pmcc/articles/PMC3766405/
  2679. \For SNP1, the allele (A) we found to be associated with better cognition and higher QOL has previously been associated with lower serotonin levels
  2680. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T3/?report=objectonly
  2681. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T2/?report=objectonly
  2682.  
  2683. 013b: 11q; TPH1 (CC;) Position: 18060353
  2684. \http://www.pdgene.org/view?poly=rs684302
  2685. \http://pubmedcentralcanada.ca/pmcc/articles/PMC3766405/
  2686. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T3/?report=objectonly
  2687. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T2/?report=objectonly
  2688.  
  2689. 013c: 11q; TPH1 (TT;) Position: 18055304
  2690. \http://www.pdgene.org/view?poly=rs211105
  2691. \http://pubmedcentralcanada.ca/pmcc/articles/PMC3766405/
  2692. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T3/?report=objectonly
  2693. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T2/?report=objectonly
  2694.  
  2695. 013d: 11q; TPH1 (CC;) Position: 18047816
  2696. \http://www.pdgene.org/view?poly=rs1800532
  2697. \http://pubmedcentralcanada.ca/pmcc/articles/PMC3766405/
  2698. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T3/?report=objectonly
  2699. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T2/?report=objectonly
  2700.  
  2701. 014: 12q; TPH2 (GG;) Position: 72331923
  2702. \http://www.pdgene.org/view?poly=rs4570625
  2703. \http://pubmedcentralcanada.ca/pmcc/articles/PMC3766405/
  2704. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T3/?report=objectonly
  2705. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766405/table/T2/?report=objectonly
  2706.  
  2707. 014b: 12q; TPH2 (TT;) Position: 71979053
  2708. \https://www.snpedia.com/index.php/Rs120074176
  2709. \http://www.nature.com/mp/journal/v13/n4/full/4002152a.html?foxtrotcallback=true
  2710.  
  2711. 015: 11q; TYR (CC;) Position: 89178528
  2712. \https://www.snpedia.com/index.php/Rs1042602
  2713. \https://omim.org/entry/606933#8
  2714. >SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN [...] SKIN/HAIR/EYE PIGMENTATION 3, FRECKLING, INCLUDED TYR, SER192TYR [...] Based on analysis of HapMap samples, the A allele of rs1042602, associated with the absence of freckles, is found at a frequency of approximately 35% in European populations, while the ancestral C allele is fixed in Asian and Nigerian Yoruba populations
  2715.  
  2716. 015b: 11q; TYR (GG;) Position: 89277878
  2717. \https://www.snpedia.com/index.php/Rs1393350
  2718. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1393350
  2719. >Frequency = CEU(AA=0.079, AG=0.292, GG=0.628,) HCB(GG=1.000,) YRI(GG=1.000)
  2720. \https://www.ncbi.nlm.nih.gov/m/pubmed/17952075/
  2721. >The association of the A allele of rs1393350 with blue versus green eye color was close to reaching genome-wide significance [...] Red versus non-red hair = rs1393350-A = Discovery OR(1.04,) Replication OR(1.05,) Netherlands OR(0.79) [...] Blond versus brown hair = rs1393350-A = Discovery OR(1.29,) Replication OR(1.36,) Netherlands OR(1.22)
  2722.  
  2723. 016: 9q; TYRP1 (CC;) Position: 12672097
  2724. \https://www.snpedia.com/index.php/Rs1408799
  2725. \https://www.nature.com/articles/jhg201138
  2726. >Green versus non-green eye colour is, according to MDR, best predicted by a three-factor model consisting of rs12913832 in HERC2, rs1408799 in TYRP1 and rs1800407 in OCA2 [...] The rs12913832 position removes 0.28% of ‘uncertainty’ in green eye colour prediction, rs1408799 removes 0.23% and the interaction between them eliminates an additional 1.23%
  2727. \https://www.nature.com/articles/jhg201138/figures/2
  2728. >rs12913832-TT, rs1408799-CC = Green eyes(n=21,) non-Green eyes(n=112)
  2729.  
  2730. 016b: 9q; TYRP1 (-;-) Position: 12695626
  2731. \https://www.snpedia.com/index.php/Rs104894130
  2732. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=104894130
  2733. >T(Ser) -> G(Del)
  2734. \https://www.omim.org/entry/115501#2
  2735. >ALBINISM, OCULOCUTANEOUS, TYPE II, MODIFIER OF, INCLUDED TYRP1, SER166TER [...] Chiang et al. (2008) reported a Hispanic girl with oculocutaneous albinism type II (OCA2; 203200) caused by compound heterozygous mutations in the OCA2 gene (611409). She had pale skin, blue irides, and visual defects, including horizontal nystagmus, irides that transilluminated light, absence of foveal reflexes, albinotic fundi, and decreased visual acuity. However, she also had curly reddish-blonde hair, which was unusual for the OCA2 phenotype [...] Further genetic analysis identified heterozygosity for the S166X mutation in the TYRP1 gene in the girl
  2736. \http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=79433
  2737. >Visual anomalies, such as nystagmus, are frequently undetectable and patients usually present with one of two phenotypes: rufous OCA (ROCA), characterized by red-bronze skin color, blue or brown irises and ginger-red hair, or brown OCA (BOCA), characterized by light to brown hair and a light to brown or tan skin color. The clinical features of OCA3 have been considered as rather mild, and in the rare cases of non-African patients, reddish hair color has been reported
  2738.  
  2739. 016c: 9q; TYRP1 (AA;) Position: 12702424
  2740. \https://www.snpedia.com/index.php/Rs281865424
  2741. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=281865424
  2742. >G(R, Arg) -> A(Q, Gln)
  2743. \https://www.omim.org/entry/115501#4
  2744. >In a Caucasian German boy with oculocutaneous albinism (OCA3; 203290), Rooryck et al. (2006) identified compound heterozygosity for mutations in the TYRP1 gene: a 1066G-A transition in exon 5, resulting in an arg356-to-glu (R356E [...] patient had yellow-gold hair with orange highlights, fair eyelashes, blue-green eyes with defects of the iris and nystagmus, several pigmented nevi, and pale yellow skin that did not tan but burned easily
  2745.  
  2746. 016d: 9q; TYRP1 (-;-) Position: 12704547
  2747. \https://www.snpedia.com/index.php/Rs387906560
  2748. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=387906560
  2749. >A(K, Lys) -> ;(S, Ser)
  2750. \https://www.omim.org/entry/115501#4
  2751. >In an African American fraternal twin with type III oculocutaneous albinism (OCA3; 203290), Boissy et al. (1996) found a single basepair deletion (A) in codon 368 in exon 6 of the TYRP1 gene, which led to a premature stop at codon 384 [...] Manga et al. (1997) analyzed the TYRP1 gene in 19 unrelated southern African blacks with so-called 'rufous' OCA (ROCA) and identified compound heterozygosity for 368delA and a ser166-to-ter nonsense mutation (S166X; 115501.0002) in 17 of the 19 patients
  2752.  
  2753. 016e: 9q; TYRP1 (-;-) Position: 12702414
  2754. \https://www.snpedia.com/index.php/Rs387906562
  2755. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=387906562
  2756. >AAC(N, Asn) -> -(V, Val)
  2757. \https://www.omim.org/entry/115501#6
  2758. >ALBINISM, OCULOCUTANEOUS, TYPE III [...] In a boy of Asian Indian origin with oculocutaneous albinism (OCA3; 203290), who had reddish hair color, brown irides, nystagmus, and lightly pigmented skin, Chiang et al. (2009) identified homozygosity for a 4-bp deletion (1057delAACA) in exon 5 of the TYRP1 gene. The unaffected parents were both heterozygous for the deletion
  2759.  
  2760. U
  2761.  
  2762. 001: 2q; UGT1A1 (TAn=8;) Position: 233760234
  2763. \https://www.snpedia.com/index.php/Rs34815109
  2764. \https://www.ncbi.nlm.nih.gov/m/pubmed/3999324/
  2765. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=3064744
  2766.  
  2767. 001b: 2q; UGT1A1 (GG;) Position: 233763993
  2768. \https://www.snpedia.com/index.php/Rs6742078
  2769.  
  2770. 001c: 2q; UGT1A1 (GG;) Position: 233759924
  2771. \https://www.snpedia.com/index.php/Rs887829
  2772.  
  2773. 001d: 2q; UGT1A1 (GG;) Position: 233763993
  2774. \https://www.snpedia.com/index.php/Rs6742078
  2775.  
  2776. 001e: 2q; UGT1A1 (CC;) Position: 233770738
  2777. \https://www.snpedia.com/index.php/Rs11563251
  2778. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838666/table/T3/?report=objectonly
  2779. \https://www.cdc.gov/cholesterol/facts.htm
  2780.  
  2781. 002: 21q; UMODL1 (TT;) Position: 42134346
  2782. \https://www.snpedia.com/index.php/Rs2839471
  2783. \https://www.ncbi.nlm.nih.gov/m/pubmed/18535602/
  2784. \http://iovs.arvojournals.org/article.aspx?articleid=2124443
  2785.  
  2786. 003: 20q; UQCC1 (CC;) Position: 35319358
  2787. \https://www.snpedia.com/index.php/Rs6060369
  2788. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914680/table/T2/?report=objectonly
  2789.  
  2790. V
  2791.  
  2792. 001: 12q; VDR (AA;) Position: 47879016
  2793. \https://www.snpedia.com/index.php/Rs121909790
  2794. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7745/
  2795.  
  2796. 001b: 12q; VDR (AA;) Position: 47865106
  2797. \https://www.snpedia.com/index.php/Rs121909791
  2798. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7746/
  2799.  
  2800. 001c: 12q; VDR (AA;) Position: 47846679
  2801. \https://www.snpedia.com/index.php/Rs121909792
  2802. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7747/
  2803.  
  2804. 001d: 12q; VDR (AA;) Position: 47865085
  2805. \https://www.snpedia.com/index.php/Rs121909793
  2806. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7749/
  2807.  
  2808. 001e: 12q; VDR (AA;) Position: 47865175
  2809. \https://www.snpedia.com/index.php/Rs121909794
  2810. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7750/
  2811.  
  2812. 001f: 12q; VDR (TT;) Position: 47857512
  2813. \https://www.snpedia.com/index.php/Rs121909795
  2814. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7751/
  2815.  
  2816. 001g: 12q; VDR (TT;) Position: 47846743
  2817. \https://www.snpedia.com/index.php/Rs121909796
  2818. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7752/
  2819.  
  2820. 001h: 12q; VDR (AA;) Position: 47878977
  2821. \https://www.snpedia.com/index.php/Rs121909797
  2822. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7753/
  2823.  
  2824. 001i: 12q; VDR (GG;) Position: 47846444
  2825. \https://www.snpedia.com/index.php/Rs121909798
  2826. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7754/
  2827.  
  2828. 001j: 12q; VDR (GG;) Position: 47846444
  2829. \https://www.snpedia.com/index.php/Rs121909799
  2830. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7755/
  2831.  
  2832. 001k: 12q; VDR (GG;) Position: 47844859
  2833. \https://www.snpedia.com/index.php/Rs121909800
  2834. \https://www.ncbi.nlm.nih.gov/clinvar/?term=rs121909800
  2835.  
  2836. 001l: 12q; VDR (AA;) Position: 47846374
  2837. \https://www.snpedia.com/index.php/Rs121909802
  2838. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7748/
  2839.  
  2840. 001m: 12q; VDR (AA;) Position: 47846052
  2841. \https://www.snpedia.com/index.php/Rs1544410
  2842. \https://www.ncbi.nlm.nih.gov/m/pubmed/10770213/
  2843.  
  2844. 001n: 12q; VDR (AA;) Position: 47844994
  2845. \https://www.snpedia.com/index.php/Rs267607169
  2846. \https://www.ncbi.nlm.nih.gov/clinvar/variation/7759/
  2847.  
  2848. 001o: 12q; VDR (CC;) Position: 47844840
  2849. \https://www.snpedia.com/index.php/Rs886037890
  2850. \https://www.ncbi.nlm.nih.gov/clinvar/variation/264697/
  2851.  
  2852. 002: 6q; VEGFA (GG;) Position: 43758873
  2853. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=6905288
  2854. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  2855. >aEffect Allele: WHR increasing allele on the forward strand;
  2856. >VEGFA, EA = A
  2857.  
  2858. 003: 8q; VMAT1 (GG;) Position: 20180955
  2859. \https://www.snpedia.com/index.php/Rs2270641
  2860. \https://www.ncbi.nlm.nih.gov/m/pubmed/18451639/
  2861. \https://www.ncbi.nlm.nih.gov/m/pubmed/28476685/
  2862.  
  2863. W
  2864.  
  2865. 001: 2q; Wnt6 (GG;) Position: 218860595
  2866. \https://www.snpedia.com/index.php/Rs6747776
  2867. \https://www.ncbi.nlm.nih.gov/pubmed/21547848?dopt=Abstract
  2868.  
  2869. 001b: 2q; Wnt6 (GG;) Position: 218867420
  2870. \https://www.snpedia.com/index.php/Rs6754599
  2871. \https://www.ncbi.nlm.nih.gov/pubmed/21547848?dopt=Abstract
  2872.  
  2873. X
  2874. Y
  2875. Z
  2876.  
  2877. 001: 22q; ZDHHC8 (GG;) Position: 20140031
  2878. \https://www.snpedia.com/index.php/Rs175174
  2879. \https://www.ncbi.nlm.nih.gov/m/pubmed/15489219/
  2880.  
  2881. 002: 22q; ZNRF3 (GG;) Position: 29451671
  2882. \https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4823006
  2883. \https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000924/table/T1/?report=objectonly
  2884. >aEffect Allele: WHR increasing allele on the forward strand;
  2885. >ZNRF3, EA = A
  2886.  
  2887. 002b: 22q; ZNRF3 (TT;) Position: 28904318
  2888. \https://www.snpedia.com/index.php/Rs16986825
  2889. \https://www.ncbi.nlm.nih.gov/pubmed/25086665?dopt=Abstract
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement